Louisiana Tech University

Louisiana Tech Digital Commons
Doctoral Dissertations

Graduate School

Spring 2016

Enhanced bioactive scaffolds for bone tissue
regeneration
Sonali Karnik

Follow this and additional works at: https://digitalcommons.latech.edu/dissertations
Part of the Biomedical Engineering and Bioengineering Commons, and the Nanoscience and
Nanotechnology Commons

ENHANCED BIOACTIVE SCAFFOLDS FOR BONE TISSUE REGENERATION

by
Sonali Kamik M. Sc., M. S.

A Dissertation Presented in Partial Fulfillment
o f the Requirements of the Degree
Doctor o f Philosophy

COLLEGE OF ENGINEERING AND SCIENCES
LOUISIANA TECH UNIVERSITY
May 2016

ProQuest Number: 10301326

All rights reserved
INFORMATION TO ALL USERS
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.

ProQuest
Que
ProQuest 10301326
Published by ProQuest LLC(2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States Code.
Microform Edition © ProQuest LLC.
ProQuest LLC
789 East Eisenhower Parkway
P.O. Box 1346
Ann Arbor, Ml 48106-1346

LOUISIANA TECH UNIVERSITY
THE GRADUATE SCHOOL

II | I' T |
D ate

We

by

hereby

recom m end

that

the

dissertation

prepared

under

our

supervision

Sonali Karnik
________________________________________________________________________

entitled____________________________________________________________________________________________________

Enhanced Bioactive Scaffolds for Bone Tissue Regeneration

be

accepted

in

partial

fulfillm ent

of

the

requirem ents

for

the

D egree

of

Doctorate in Biomedical Engineering

rvisor o f Dissertation Research

Head o f Department

ShJtz /

/2 io

C.
Department

R ecom m end ation concurred in:

A dvisory C om m ittee

Approved:

Director o f Graduate Studies

jproved:

5ean o f the Grauuate School

jrsmm / tec
Dean o f the C ollege
GS Form 13a
(6/0 7 )

ABSTRACT
Bone injuries are commonly termed as fractures and they vary in their severity
and causes. If the fracture is severe and there is loss of bone, implant surgery is
prescribed. The response to the implant depends on the patient’s physiology and implant
material. Sometimes, the compromised physiology and undesired implant reactions lead
to post-surgical complications. [4,5,20,28] Efforts have been directed towards the
development o f efficient implant materials to tackle the problem of post-surgical implant
failure. [15,19,24,28,32]
The field o f tissue engineering and regenerative medicine involves the use of cells
to form a new tissue on bio-absorbable or inert scaffolds. [2, 32] One of the applications
o f this field is to regenerate the damaged or lost bone by using stem cells or
osteoprogenitor cells on scaffolds that can integrate in the host tissue without causing any
harmful side effects. [2,32] A variety of natural, synthetic materials and their
combinations have been used to regenerate the damaged bone tissue. [2, 19,30,32,43]
Growth factors have been supplied to progenitor cells to trigger a sequence o f
metabolic pathways leading to cellular proliferation, differentiation and to enhance their
functionality. [56, 57] The challenge persists to supply these proteins, in the range of
nano or even picograms, and in a sustained fashion over a period of time. A delivery
system has yet to be developed that would mimic the body’s inherent mechanism of

delivering the growth factor molecules in the required amount to the target organ or
tissue.
Titanium is the most preferred metal for orthopedic and orthodontic implants. [28,
46,48] Even though it has better osteogenic properties as compared to other metals and
alloys, it still has drawbacks like poor integration into the surrounding host tissue leading
to bone resorption and implant failure. [20,28, 35] It also faces the problem o f postsurgical infections that contributes to the implant failure. [26, 37]
The focus of this dissertation was to design and develop novel implant materials
for coating titanium to improve its biological properties. These natural and/or semi
synthetic materials improved cellular adhesion, biological response to the scaffolds and
prevented growth o f bacteria when they were enhanced with growth factor and antiinfective loaded nanotubes. The implant materials showed promise when tested in vitro
for cell proliferation, differentiation and bacterial growth inhibition.

APPROVAL FOR SCHOLARLY DISSEMINATION
The author grants to the Prescott Memorial Library of Louisiana Tech University
the right to reproduce, by appropriate methods, upon request, any or all portions of this
Dissertation. It is understood that “proper request” consists of the agreement, on the part
of the requesting party, that said reproduction is for his personal use and that subsequent
reproduction will not occur without written approval of the author of this Dissertation.
Further, any portions o f the Dissertation used in books, papers, and other works must be
appropriately referenced to this Dissertation.
Finally, the author o f this Dissertation reserves the right to publish freely, in the
literature, at any time, any or all portions of this Dissertation.

Author

Date Q T | < p 2 - ) ^ ' g

GS Form 14
(8/ 10)

DEDICATION
This dissertation is dedicated to my father, Late Mr. Jayant Kamik, whose faith in
my dream to be a researcher has been a pillar of strength so far. It is also dedicated to my
maternal uncle, Mr. Dilip Tamhane, who encouraged my curious nature and love of
science. Lastly and most importantly, to my mother, Mrs. Sushama J. Kamik, whose
support and love has been a driving force in my life.

TABLE OF CONTENTS
Abstract....................................................................................................................................iii
Dedication................................................................................................................................vi
List of Tables......................................................................................................................... xii
List of Figures....................................................................................................................... xiii
Acknowledgement................................................................................................................ xxi
Chapter 1 Introduction and Background................................................................................. 1
1.1

Skeletal Tissue System and Bone...........................................................................2

1.1.1

Bone..................................................................................................................... 2

1.1.2

Types o f B ones................................................................................................... 3

1.1.3

Cellular Components o f Bones..........................................................................4

1.2

Bone Injuries and Tissue Repair.............................................................................5

1.3

Current Treatment Modalities................................................................................. 6

1.3.1

1.3.1.1

Autografts....................................................................................................7

1.3.1.2

Allografts.....................................................................................................8

1.3.2

1.4

Biological Implants............................................................................................. 7

Non-biological Implants.....................................................................................8

1.3.2.1

Metal implants............................................................................................ 8

1.3.2.2

Polymer implants........................................................................................ 8

Clinical Need for Improved Implant Materials......................................................9

Chapter 2 Tissue Engineering and Enhanced Materials in Regenerative Medicine
2.1

10

Rationale behind the Three Integrated Projects................................................... 12

2.2

Nanoenhanced Bioactive Hydrogels...................................................................... 14

2.3

Nanoseeds................................................................................................................16

2.4

Hydrogel Biocoatings for Titanium Implants.........................................................17

2.5

Objectives o f the Projects.......................................................................................19

Chapter 3 Instrumentation and Methods...............................................................................21
3.1

Instruments...............................................................................................................21

3.1.1

HIT ACHIS 4800 Field Emission-Scanning Electron Microscope and
EDX.....................................................................................................................21

3.1.2 NOVA e2000 B. E. T. Surface Area and PoreSize Analyzer......................... 22
3.1.3 NANODROP 2000 Spectrophotometer........................................................... 23
3.1.4 Olympus BX51 Fluorescent Microscope..........................................................24
3.1.5 LABCONCO Lyophilizer..................................................................................25
3.1.6 Absorbance Microplate Reader......................................................................... 26
3.1.7 Anodization Set-Up........................................................................................... 27
3.2

M ethods...................................................................................................................28

3.2.1 Preparation of Hydrogels...................................................................................28
3.2.2 Vacuum Loading of Halloysite......................................................................... 29
3.2.2.1

Loading HNTs with growth factors.........................................................30

3.2.2.2

Loading HNTs with anti-microbial agent............................................... 30

3.2.3 Sample Preparation for FE-SEM ...................................................................... 31
3.2.4 Coating 12 Well Plates with Collagen Type I G els........................................31
3.2.5 Cell Assays..........................................................................................................32
3.2.5.1

Trypan Blue cell count for seeding density............................................ 32

3.2.5.2

NucBlue fluorescent staining................................................................... 32

3.2.5.3

Alcian Blue staining.................................................................................33

3.2.5.4

Picrosirius Red staining............................................................................33

3.2.5.5

Von Kossa staining................................................................................... 34

3.2.6

Release Profile study.........................................................................................34

3.2.7

Bacterial Inhibition study................................................................................. 35

Chapter 4 Nanoenhanced Bioactive Hydrogels................................................................... 37
4.1

Introduction............................................................................................................ 37

4.2

Materials and Methods.......................................................................................... 38

4.2.1

Cell culture, Cell Seeding and Preparation of the Constructs........................38

4.2.2

Sample Fixation and Histochemical Analyses................................................ 39

4.2.3

Release Profile Study for BMP 2 .....................................................................39

4.2.4

FE-SEM Imaging and Material Testing.......................................................... 40

4.3

Results and Discussion......................................................................................... 40

4.3.1

Histochemical Analysis................................................................................... 40

4.3.1.1

Alcian Blue staining................................................................................. 41

4.3.1.2

Picrosirius Red staining............................................................................ 58

4.3.1.3

Von Kossa staining....................................................................................73

4.3.2

Release Profile Study of BMP 2 from HNTs.................................................. 85

4.3.3

FE-SEM Imaging and Material Testing with BET Pore Size and Surface
Area Analyses...................................................................................................90

4.3.3.1

FE-SEM imaging.......................................................................................90

4.3.3.2

BET pore size and surface area analysis of hydrogels........................... 92

Chapter 5 Nanoseeds.............................................................................................................. 97
5.1

Introduction............................................................................................................ 97

5.2

Materials and methods.......................................................................................... 98

5.2.1

Cell Migration Study......................................................................................... 98

5.2.1.1

Coating cell culture well plates and seeding........................................... 98

5.2.1.2

Fixing the gel matrices and histochemical staining.................................99

5.2.2

Release Profile Study of BMP 2 from HNTs and Various Hydrogel
Composites........................................................................................................ 99

5.2.3 FE-SEM Imaging and Comparison of Surface Morphologies of Different
Hydrogel Composites......................................................................................100
5.2.4
5.3

Preosteoblast Pilot Study Using the Composite Hydrogels..........................100
Results and Discussion........................................................................................101
Histochemical Analysis.................................................................................. 101

5.3.1

5.3.1.1

Alcian Blue staining............................................................................... 101

5.3.1.2

Von Kossa staining................................................................................109

5.3.1.3

Preosteoblast pilot study on the composite hydrogels..........................116

5.3.2

Release Study o f BMP 2 from HNTs and Various Hydrogel
Composites........................................................................................................120

5.3.2.1

Release profile of BMP 2 from HNTs..................................................121

5.3.2.2

Release profile of BMP 2 from HNT enhanced hydrogels................ 125

5.3.3

FE-SEM Imaging and Comparison o f the Hydrogel Composites
Surface Morphologies.....................................................................................126

Chapter 6 Hydrogel Coatings for Titanium Implants........................................................ 131
6.1

Introduction.......................................................................................................... 131

6.2

Materials and Methods.....................................................................133

6.2.1

Anodization of Titanium................................................................................133

6.2.1.1
6.2.2

SBF study on the osteogenic properties of anodized titanium

133

Bacterial Inhibition Study on the GS-HNT Enhanced Hydrogel
Constructs........................................................................................................ 133

6.2.3 Release Profile Study of GS from HNTs and Hydrogels Enhanced with
HNTs................................................................................................................ 134
6.3

Results and Discussion.................................................................... 134

6.3.1

FE-SEM Imaging of the Anodized Titanium............................................... 134

6.3.1.1

FE-SEM imaging and EDX of the SBF- titanium study......................136

6.3.2 Bacterial Inhibition Study on the GS-HNT Enhanced Hydrogel
Constructs......................................................................................................... 140
6.3.3

Release Profile Study of GS from HNTs and Hydrogels Enhanced with
HNTs.................................................................................................................144

Chapter 7 Conclusions and Future Work............................................................................ 150
References............................................................................................................................. 154
APPENDIX A Image Analysis............................................................................................160
APPENDIX B Release Study Plot and Error B ars............................................................ 162
APPENDIX C Experiments with Inconlusive Results and Failures................................. 165

LIST OF TABLES

Table 1: Materials in specific concentrations used for hydrogel composites................... 29
Table 2: BET results summary............................................................................................. 95
Table 3: Result of the image analysis o f the bacterial plates............................................144

LIST OF FIGURES

Figure 1-1: Graphical Representation of the Bone Anatomy............................................... 3
Figure 1-2: Graphical Representation of Phases of Bone Healing...................................... 6
Figure 2-1: Graphical representation of the rationale behind the three interrelated
projects.....................................................................................................................................14
Figure 2-2: Graphical representation of the concept of nanoenhanced bioactive
hydrogels..................................................................................................................................16
Figure 2-3: The experimental design and the concept of Nanoseed.................................. 17
Figure 2-4: Graphical representation of the concept of hydrogel coatings for
anodized titanium.................................................................................................................... 19
Figure 3-1: HITACHI S 4800 FE-SEM at Institute of Micromanufacturing,
Louisiana Tech University.....................................................................................................22
Figure 3-2: NOVA e2000 Surface Area and Pore Size Analyzer at Institute of
Micrmanufacturing, Louisiana Tech University.................................................................. 23
Figure 3-3: Thermo Scientific NANODROP 2000 Spectrophotometer............................24
Figure 3-4: Olympus BX51 epifluorescence microscope in BME microscopy lab,
Louisiana Tech University.....................................................................................................25
Figure 3-5: LABCONCO lyophilizer in BME 151, Louisiana Tech University..............26
Figure 3-6: Phenix LT-4000 absorbance microplate reader in BME 238, Louisiana
Tech University.......................................................................................................................27
Figure 3-7: Anodization set-up at Carson-Taylor Hall room 316, Louisiana Tech
University................................................................................................................................ 28
Figure 4-1: Alcian Blue staining Day 0 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+
HNTs+ BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6 ........................................... 42

xiv

Figure 4-2: Alcian Blue staining Day 7 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+
HNTs+ BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6 ........................................... 43
Figure 4-3: Alcian Blue staining Day 14 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+
HNTs+ BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6 ........................................... 44
Figure 4-4: Alcian Blue staining Day 21 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+
HNTs+ BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6 ........................................... 46
Figure 4-5: Image analysis for Alcian Blue staining for Control 1 Day 0........................ 48
Figure 4-6: Image analysis for Alcian Blue staining for Control 1 Day 21...................... 49
Figure 4-7: Image analysis for Alcian Blue staining for Control 2 Day 0.........................50
Figure 4-8: Image analysis for Alcian Blue staining for Control 2 Day 21...................... 51
Figure 4-9: Image analysis for Alcian Blue staining for Experimental 1 Day 0 .............. 52
Figure 4-10: Image analysis for Alcian Blue staining for Experimental 1 Day 2 1 ..........53
Figure 4-11: Image analysis for Alcian Blue staining for Experimental 3 Day 0 ............54
Figure 4-12: Image analysis for Alcian Blue staining for Experimental 3 Day 2 1 ..........55
Figure 4-13: Image analysis for Alcian Blue staining for Experimental 4 Day 0 ............56
Figure 4-14: Image analysis for Alcian Blue staining for Experimental 4 Day 2 1 ..........57
Figure 4-15: Picrosirius Red staining Day 0 A) Control 1 Alginate-only
B) Control 2 Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D)
Experimental 2 Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3
Alginate+ HNTs+ BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6 ....................... 58
Figure 4-16: Picrosirius Red staining Day 7 A) Control 1 Alginate-only
B) Control 2 Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D)
Experimental 2 Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3
Alginate+ HNTs+ BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6 ........................59

XV

Figure 4-17: Picrosirius Red staining Day 14 A) Control 1 Alginate-only
B) Control 2 Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D)
Experimental 2 Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3
Alginate+ HNTs+ BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6 ....................... 60
Figure 4-18: Picrosirius Red staining Day 21 A) Control 1 Alginate-only B) Control
2 Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+
HNTs+ BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6 ........................................... 61
Figure 4-19: Image analysis for PicrosiriusRed staining for Control 1 Day 0..................63
Figure 4-20: Image analysis for PicrosiriusRed staining for Control 1 Day 21................64
Figure 4-21: Image analysis for PicrosiriusRed staining for Control 2 Day 0..................65
Figure 4-22: Image analysis for Picrosirius Red staining for Control 2 Day 21............ 66
Figure 4-23: Image analysis for Picrosirius Red staining for Experimental 1 Day 0 .......67
Figure 4-24: Image analysis for Picrosirius Red staining for Experimental 1 Day 21.... 68
Figure 4-25: Image analysis for Picrosirius Red staining for Experimental 2 Day 0 .......69
Figure 4-26: Image analysis for Picrosirius Red staining for Experimental 3 Day 21.... 70
Figure 4-27: Image analysis for Picrosirius Red staining for Experimental 4 Day 0 .......71
Figure 4-28: Image analysis for Picrosirius Red staining for Experimental 4 Day 21.... 72
Figure 4-29: Von Kossa staining Day 0 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+
HNTs+ BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6 ..........................................73
Figure 4-30: Von Kossa staining Day 7 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+
HNTs+ BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6 .......................................... 74
Figure 4-31: Von Kossa staining Day 14 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+
HNTs+ BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6 ........................................... 75

xvi

Figure 4-32: Von Kossa staining Day 21 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+
HNTs+ BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6 ........................................... 76
Figure 4-33: Grayscale intensity for Von Kossa staining for alginate for alginateonly hydrogel control 1 (C l) for Day 0 ................................................................................ 77
Figure 4-34: Grayscale intensity for Von Kossa staining for alginate-only
hydrogel control 1 (C l) for Day 2 1 ...............................

78

Figure 4-35: Grayscale intensity for Von Kossa staining for alginate+ hydrogel
control 2 (C2) for Day 0......................................................................................................... 78
Figure 4-36: Grayscale intensity for Von Kossa staining for alginate+ hydrogel
control 2 (C2) for Day 21....................................................................................................... 79
Figure 4-37: Grayscale intensity for Von Kossa staining for alginate+ HNTs+
BMP 2 experimental 1 (E l) for Day 0 .................................................................................. 80
Figure 4-38: Grayscale intensity for Von Kossa staining for alginate+ HNTs+
BMP 2 experimental 1 (E l) for Day 21................................................................................ 80
Figure 4-39: Grayscale intensity for Von Kossa staining for alginate+ HNTs+
BMP 4 experimental 3 (E3) for Day 0 .................................................................................. 81
Figure 4-40: Grayscale intensity for Von Kossa staining for alginate+ HNTs+
BMP 4 experimental 3 (E3) for Day 21................................................................................ 82
Figure 4-41: Grayscale intensity for Von Kossa staining for alginate+ HNTs+
BMP 6 experimental 4 (E4) for Day 0 .................................................................................. 83
Figure 4-42: Grayscale intensity for Von Kossa staining for alginate+ HNTs+
BMP 6 experimental 4 (E4) for Day 21................................................................................ 83
Figure 4-43: Calibration curve for BMP 2 standards......................................................... 85
Figure 4-44: Graph showing conversion of absorbance to logconcentrations................ 86
Figure 4-45: Release profile of BMP 2 from HNTs for 24 hours.......................................87
Figure 4-46: The graph of the release profile study for BMP 2 from HNTs for 7
days..........................................................................................................................................88
Figure 4-47: FE-SEM images showing A) Alginate-only bead and B) Alginate+
HNTs bead.............................................................................................................................. 90

Figure 4-48: FE-SEM images showing the surface morphology of A)
Alginate-only bead 100 pm magnification B) Alginate+ HNTs bead 100
pm magnification C) Alginate-only bead 1 pm magnification D) Alginate+
HNTs bead with HNT protruding out of the surface at 1 pm
magnification.......................................................................................................................... 91
Figure 4-49: BET Langmuir isotherm showing the adsorption-desorption of helium
for alginate-only hydrogel...................................................................................................... 93
Figure 4-50: BET Langmuir isotherm showing the adsorption-desorption of helium
for alginate-only hydrogel...................................................................................................... 94
Figure 5-1: Day 1 Alcian Blue Staining of the preosteoblast cells on collagen
matrices with hydrogel nanoseed constructs. A) Well 1 with alginate-only
hydrogels B) Well 2 with alginate+ HNT+ BMP 2 C) Well 3 alginate+ CPC +
HNT D) Well 4 alginate + CPC+ HNT+ BMP 2 E) Well 5 alginate+ CPC+
Chitosan lactate + HNT F) Well 6 alginate+ CPC+ Chitosan lactate +
HNT+ BMP 2........................................................................................................................ 102
Figure 5-2: Day 3 Alcian Blue staining of the preosteoblast cells on collagen
matrices with hydrogel nanoseed constructs. A) Well 1 with alginate-only
hydrogels, site of initial seeding B) Well 1 with alginate-only hydrogels,
center C) Well 2 with alginate+ HNT+ BMP 2, site of initial seeding
D) Well 2 with alginate+ HNT+ BMP 2, center E) Well 3 alginate+
CPC+ HNT, site of initial seeding F) Well 3 alginate+ CPC+ HNT,
center G) Well 4 alginate + CPC+ HNT+ BMP 2, site of initial seeding
H) Well 4 alginate + CPC+ HNT+ BMP 2, center I) Well 5 alginate+
CPC+ Chitosan lactate + HNT, site of initial seeding J) Well 5 alginate+
CPC+ Chitosan lactate + HNT, center K) Well 6 alginate+ CPC+ Chitosan
lactate + HNT+ BMP 2, site of initial seeding L) Well 6 alginate+ CPC+
Chitosan lactate + HNT+ BMP 2, center............................................................................ 104

Figure 5-3: Day 7 Alcian Blue staining of the preosteoblast cells on
collagen matrices with hydrogel nanoseed constructs. A) Well 1
with alginate-only hydrogels, site of initial seeding B) Well 1
with alginate-only hydrogels, center C) Well 2 with alginate+
HNT+ BMP 2, site of initial seeding D) Well 2 with alginate+
HNT+ BMP 2, center and near bead (insert) E) Well 3 alginate+
CPC + HNT, site of initial seeding F) Well 3 alginate+ CPC + HNT,
center G) Well 4 alginate+ CPC+ HNT+ BMP 2, site of initial seeding
H) Well 4 alginate + CPC+ HNT+ BMP 2, center and near bead (insert)
I) Well 5 alginate+ CPC+ Chitosan lactate + HNT, site of initial seeding
J) Well 5 alginate+ CPC+ Chitosan lactate + HNT, center K) Well 6
alginate+ CPC+ Chitosan lactate+ HNT+ BMP 2, site of initial seeding
L) Well 6 alginate+ CPC+ Chitosan lactate+ HNT+ BMP 2, center and
near bead (insert)................................................................................................................... 107
Figure 5-4: Day 1 Von Kossa Staining of preosteoblast cells on collagen matrices
with hydrogel nanoseed constructs. A) Well 1 with alginate-only hydrogels B) Well 2
with alginate+ HNT+ BMP 2 C) Well 3 alginate+ CPC + HNT D) Well 4 alginate +
CPC+ HNT+ BMP 2 E) Well 5 alginate+ CPC+ Chitosan lactate + HNT F) Well 6
alginate+ CPC+ Chitosan lactate + HNT+ BMP 2 .............................................................110
Figure 5-5: Day 3 Von Kossa staining of the preosteoblast cells
on collagen matrices with hydrogel nanoseed constructs. A)
Well 1 with alginate-only hydrogels, site of initial seeding
B) Well 1 with alginate-only hydrogels, center C) Well 2 with alginate+
HNT+ BMP 2, site of initial seeding D) Well 2 with alginate+ HNT+
BMP 2, center E) Well 3 alginate+ CPC+ HNT, site of initial seeding
F) Well 3 alginate+ CPC+ HNT, center G) Well 4 alginate + CPC+
HNT+ BMP 2, site of initial seeding H) Well 4 alginate + CPC+
HNT+ BMP 2, center I) Well 5 alginate+ CPC+ Chitosan lactate +
HNT, site of initial seeding J) Well 5 alginate+ CPC+ Chitosan
lactate + HNT, center K) Well 6 alginate+ CPC+ Chitosan lactate
+ HNT+ BMP 2, site of initial seeding L) Well 6 alginate+ CPC+
Chitosan lactate + HNT+ BMP 2, center...........................................................................112

xix

Figure 5-6: Day 7 Von Kossa staining of the preosteoblast cells on
collagen matrices with hydrogel nanoseed constructs. A) Well 1
with alginate-only hydrogels, site of initial seeding B) Well 1
with alginate-only hydrogels, center C) Well 2 with alginate+
HNT+ BMP 2, site of initial seeding D) Well 2 with alginate+
HNT+ BMP 2, center E) Well 3 alginate+ CPC + HNT, site
o f initial seeding F) Well 3 alginate+ CPC + HNT, center G)
Well 4 alginate+ CPC+ HNT+ BMP 2, site of initial seeding
H) Well 4 alginate + CPC+ HNT+ BMP 2, center and near bead (insert)
I) Well 5 alginate+ CPC+ Chitosan lactate + HNT, site of initial seeding
J) Well 5 alginate+ CPC+ Chitosan lactate + HNT, center K) Well 6
alginate+ CPC+ Chitosan lactate+ HNT+ BMP 2, site of initial seeding
L) Well 6 alginate+ CPC+ Chitosan lactate+ HNT+ BMP 2, center and
near bead (insert)................................................................................................................... 115
Figure 5-7: Graph showing the absorbance (at 450-495 nm) of the eluted Alcian
Blue stain against the number of days. (n=6), p<0.05. Error bars show standard
deviation.................................................................................................................................117
Figure 5-8: Graph showing the absorbance (at 620-750 nm) of the eluted Picrosirius
Red stain against the number of days. (n=6), p<0.05. Error bars show standard
deviation.................................................................................................................................118
Figure 5-9: Calibration curve for BMP 2 standards with absorbance and the
corresponding concentrations.............................................................................................. 121
Figure 5-10: Graph for conversion for the absorbance values to corresponding
concentrations....................................................................................................................... 122
Figure 5-11: Graph showing release of BMP 2 from the HNTsfor 24 hours..................122
Figure 5-12: Graph showing the release profile of BMP 2 from HNTs for7 days

124

Figure 5-13: Graph of release profile of BMP 2from hydrogels enhancedwith
HNTs...................................................................................................................................... 125
Figure 5-14: A comparison of different hydrogel constructs surface morphologies
at higher magnification.........................................................................................................127
Figure 5-15: FE-SEM images of A) alginate-only B) alginate+ HNTs C) alginate+
CPC and D) alginate+ CPC+ Chitosan showing the surface morphology at 100 pm
magnification........................................................................................................................ 128
Figure 5-16: FE-SEM images of A) alginate-only B) alginate+ HNTs C) alginate+
CPC and D) alginate+ CPC+ Chitosan showing the surface morphology at 10 pm
magnification.........................................................................................................................129

XX

Figure 6-1: Graphical representation of the anti-microbial hydrogel (H)
coating applied to anodized titanium (AT). From left to right, bacteria
(B) encounter the anti-microbial hydrogel and released gentamicin
(G) altering their metabolism leading to cell death. T = titanium.....................................132
Figure 6-2: Titanium surfaces after anodization at 5pm magnification A) 1 minute
B) 2 minutes C) 3 minutes D) 4 minutes and E) Non-anodized titanium (control) at
10 pm magnification.............................................................................................................135
Figure 6-3: EDX analysis of control titanium sheet in SBF for 7 days........................... 136
Figure 6-4: EDX analysis o f 4 minutes anodized titanium in SBF for 7 day s............... 137
Figure 6-5: FE-SEM images of A) non-anodized and B) 4 minute anodized
titanium after 7 days in SBF with the marked area showing hydroxyapatite
crystal at 50 pm ..................................................................................................................... 138
Figure 6-6: FE-SEM images showing the different surfaces of Titanium and the
hydroxyapatite crystals after immersing in SBF for 7 days at 2 pm A) ControlNon-anodized titanium B) 1 minute anodized titanium C) 2 minutes anodized
titanium D) 3 minutes anodized titanium E) 4 minutes anodized titanium ......................139
Figure 6-7: Negative control plate with no bacteria and/ or anti-infective agent G S.... 141
Figure 6-8: Positive control plate with bacterial lawn and no anti-infective agent
G S .......................................................................................................................................... 141
Figure 6-9: Bacterial growth inhibition studies (A) Alginate+ HNTs+ CPC+
chitosan, alginate+ HNTs+ CPC, alginate-only, and alginate+ HNTs on LB
agar plate. (B) Gentamicin control disk (60 mg gentamicin) shows a large
zone of inhibition, (b) E. coli growing as a continuous lawn.(C) MuellerHinton plate with hydrogels with gentamicin sulfate showing zones of
inhibition (top) alginate+ HNTs+ CPC+ chitosan+ gentamicin, (bottom)
alginate+ HNTs+ CPC+ gentamicin, (D) alginate+ HNTs+ gentamicin, (n=6)...............142
Figure 6-10: Calibration curve for GS used to calculate GS concentrations released
from HNTs for 7 days (n=6)................................................................................................ 145
Figure 6-11: The cumulative release of GS from HNTs for 7 d ay s............................... 146
Figure 6-12: Cumulative graph of gentamicin sulfate release from hydrogels
showing time (hours) vs. concentration (mg/ m l)...............................................

147

ACKNOWLEDGEMENTS
I would like to express my immense gratitude towards my mentor and guide, Dr.
David K. Mills, for defining my doctoral dissertation. I thank him for his constant
support, encouragement and guidance throughout my doctoral degree. Working under his
guidance has helped me learn a lot on both professional and academic levels. I would also
like to thank my advisory committee members Drs. Marie DeCoster, Steven Jones, Jamie
Newman, and Teresa Murray for their help during my ongoing research. I would like to
mention Dr. Alfred Gunasekaran for his timely help in electron microscopy imaging and
Dr. Rebecca Giomo for her assistance in bacterial studies. I wish to thank Dr. James
Spaulding for training me in tissue embedding and sectioning techniques and Dr. Sven
Eklund for his support and expertise in conducting anodization experiments on titanium.
I would like to mention here my heartfelt thanks to my fellow lab members and
friends, especially Miss Yangyang Luo, Mr. Udaybhanu Murthy Jammalamadaka, and
Mr. Karthik Tappa for helping and supporting me throughout the projects and testing
times. I would like to thank Miss Bharati Belwalkar for her help in statistical analyses for
the projects and the resulting manuscripts. I would like to mention my special thanks to
Mr. Reid Grimes for his help and expertise in anodization o f titanium and to Mr. Chris
Boyer, Mr. Jeff Ambrose, Dr. Jeff Weisman, and Mr. Lin Sun with whom I conducted the
combined studies for the scaffolds and other project collaborations.

xxi

I would also like to acknowledge all the professors who helped me gain
knowledge during the course of Master’s and Doctoral degrees and my friends from
Louisiana Tech University who are a family to me.

CHAPTER 1
INTRODUCTION AND BACKGROUND
The National Ambulatory Medical Care Survey and the American Academy of
Orthopedic Surgeons estimate that in the United States annually over 6.8 million cases of
bone injuries are brought to medical attention. [4, 5] The cause o f these bone injuries
varies from trauma in young individuals to osteoporosis or a combination of both in old
aged patients. [17] Depending upon the severity o f the injury and the patient’s
physiological condition, the treatment can vary from immobilizing the bone in a cast or
surgical implants. [17] Response to the treatments, especially in case o f implants, varies
depending upon the patient physiology and the type o f implant material. Most of the
implant materials available commercially have some drawbacks and can cause painful
complications in the patients post-surgery.
The field o f orthopedic and orthodontic tissue engineering and regenerative
medicine directs its efforts to develop novel materials that can be used to improve the
implant materials. In order to design better implants and develop improved scaffolds, we
need to understand bone injuries, bone regeneration, the current treatments and their
drawbacks. The following sections in this chapter explain in detail the skeletal system,
anatomy and physiology o f bone and summarize the current treatments and their
limitations.
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1.1

Skeletal Tissue System and Bone

Skeletal tissues are involved with the prime purpose of providing support to the
body, protection to the vital organs, and locomotion. This is achieved by wellcoordinated and concerted actions o f various tissues within the skeletal and nervous
system. The major components of the skeletal tissue system are bones, muscles, cartilage,
ligaments and tendons. The following subsections explain bone anatomy, the types of
bone, and its cellular components.
1.1.1

Bone
Bone is a connective tissue consisting o f organic and inorganic components. The

organic components of bone include an extracellular matrix and three types of cells;
osteoblasts, osteocytes and osteoclasts. The inorganic part of the bone consists of
minerals including calcium, phosphorous and magnesium which act as the body’s
reservoir of these salts. Bone has a vascular supply in the form of a network of arteries,
veins and capillaries as well as lymphatic vessels. Bone also contains marrow in its
stroma or inner hollow space which is a reservoir of stem cells that houses hemopoeitic
cells as well as skeletal tissue cells. [21,34,44] Bone is a rigid organ but is also dynamic
in nature and is able to regenerate as old bone disintegrates and a new one is formed. The
mechanism of constantly replacing old bone with a new one is achieved by bone
progenitor cells, and osteoblasts which lay new foundations and the old bone is resorbed
by bone resorptive cells, called osteoclasts. Osteoclasts release metalloproteases which
digest the old bone minerals in the matrix, giving way to new bone formation. [23,47]
Figure 1-1 shows bone anatomy in detail.
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Figure 1-1. Graphical Representation of the Bone Anatomy. [18]
1.1.2

Types o f Bones
Based on the length, bones can be classified into five types: long, short, flat,

sesamoid and irregular. The characteristics and examples of the five types are as follows:
1. Long Bone: Long bones have a shaft which is longer in length than width. The
articular surfaces o f the long bones (epiphyses) are rounded and covered
mostly with articular cartilage. The middle long and slender region
(diaphyses) is made up of compact bone. However, the rounded articulating
part is made of spongy, cancellous bone, e.g. femur, humerus and tibia. [21,
23, 34 ,44,47]
2. Short Bone: Short bones can be said to have a cubic shape and have mostly
spongy bone surrounded by a thin layer of compact bone. Examples of short
bones are the small bones of ankles and wrists. [21,23, 34 ,44,47]
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3. Flat Bone: Flat bones are curved and thin. They consist of two layers of thin
compact bone and a thin layer of spongy bone in between. They are found in
die skull and sternum. [21, 23, 3 4 ,4 4 ,4 7 ]
4. Sesamoid Bone: Bones embedded in tendons are called sesamoid bones and
are found in the articular joints like the knee joint. They resemble short bones
in their shape and carry out the function o f holding the tendon away from the
bone and increasing the muscle leverage. An example of the sesamoid bone is
the patella in the knee joint. [21,23, 3 4 ,4 4 ,4 7 ]
5. Irregular Bone: Any bone not fitting into the above categories is classified as
irregular bone. As the name suggests, these bones have irregular shapes. They
are spongy bones surrounded by a thin mass o f compact bone and are found in
die vertebral column, pelvic girdle and in the skull. [21,23, 34 ,44,47]
1.1.3

Cellular Components of Bones
Bone consists o f three types of cells: osteoblasts, osteocytes, and osteoclasts.

These cells originate in the bone marrow present in the medullary cavity. [16,23,47]
1. Osteoblasts: Osteoblasts, like other skeletal tissue cells, are derived from the
mesenchymal stem cells present in the bone marrow. They are also called
bone progenitor cells as they form the new bone matrix. A variety o f growth
factors play in concert with each other to differentiate the osteoblasts and
secretion o f bone matrix. [16,23,47]
2. Osteocytes: Osteoblasts on maturation are called osteocytes. These cells are
metabolically less active than osteoblasts but help maintain the bone matrix.
They are found in small cavities in the bone mineral matrix secreted by them,
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called lacunae and form a network of cytoplasmic processes called canaliculi.
[16,23,47]
3. Osteoclasts: Osteoclasts are large motile macrophages present in the bone
matrix and are involved in resorption of old bone matrix. Osteoclasts originate
from the hematopoietic stem cells like other macrophages, have a monocytic
lineage and inherit the property of phagocytosis. They play an important role
in calcium homeostasis. [16,23,47]

1.2

Bone Injuries and Tissue Repair

Bone injuries are generally called fractures and have various causes. [23,47, 51]
Bone can fracture due to high impact or stress as in the case o f trauma or a low impact or
stress as in cases o f osteoporosis, bone cancer, and osteogenesis imperfecta. [9,23,47,
51] When bone fracture is caused due to pathological causes such as cancer, osteoporosis,
or osteogenesis imperfecta; it is termed a pathological fracture.
The tissue repair and regeneration process in bone depends on the patient’s
physiological condition and age. [9, 51] Disorders like diabetes mellitus, osteoarthritis,
and other pathologies complicate and delay the process of tissue repair. [9, 51] Bone
healing is also slow in older patients as compared to younger patients. [9, 51]
Tissue repair in bone involves a sequence of events that uses stem cells,
osteoprogenitor cells and various molecular triggers responsible for stimulating migration
o f these cells and their differentiation. The events of bone tissue repair can be
summarized as follows and are depicted pictorially in Figure 1-2:
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1. Reactive phase (Hematoma formation): Initial inflammatory response and
secretion of cytokines and growth factors. The secretion of cytokines and growth
factors signal the progenitor cells to migrate to the site o f injury.
2. Reparative phase (Soft and Hard Callus formation): Proliferation o f the progenitor
cells that will replace the damaged tissue.
3. Remodeling phase: Differentiation of proliferated progenitor cells forming a new
tissue that will be functional just like the old tissue. [9,16,47, 51]

Figure 1-2. Graphical Representation of Phases o f Bone Healing. [3]

1.3

Current Treatment Modalities

A variety of treatment modalities are used to assist the natural repair and
regeneration response o f the body. In cases where the response is hindered due to
patients’ physiological state or complexity of the injury, natural or artificial implants are
used. The treatment also involves use of pain killers, physiotherapeutics and other
assistive drugs. [14]
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In severe cases o f fractures where the gap between the broken bones is large and
the bone structure becomes unstable, surgery is prescribed to stabilize the bones. Metal
implants (titanium plates and/or screws) are used to hold the bones in place. [14, 51] In
extreme trauma, compromised physiological condition and/ or old age, the surgery can be
a complicated procedure and healing can be problematic. [51] For convenience, the
implant materials discussed in this dissertation are broadly categorized as having a
biological and non-biological origin. The implant materials and their limitations are
described in the sections below.
1.3.1

Biological Implants
The implants that are derived from biological materials or are composed of

biological materials are categorized as biological implants. These types of implants
include biological tissues, decellularized tissue matrix, and materials isolated and purified
from the tissues o f organisms. [36,46] Focusing on the orthopedic and orthodontic
implants, the biological orthopedic and orthodontic implants are bone grafts. Depending
on the origin of bone grafts, they are further categorized into autografts and allografts.
1.3.1.1

Autoerafts. Autografts are derived from the same individual who needs the

implant. [46] The bone is usually taken from the iliac crest, spine, or ribs. The process
of surgically removing the graft from a healthy donor site is called harvesting. This type
o f implant procedure is performed in the spine fusion surgery. [46] Autograft poses
risks such as donor site morbidity, infection, chronic pain at the site o f harvesting, and
nerve injury during the harvesting procedure. [33,46] Bone autografts are employed
less in recent times due to development of better alternative methods. [15,56]
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1.3.1.2

Allografts. Allografts are harvested from cadavers by a tissue bank.

Allografts have drawbacks such as lower chances of bone fusion, risk of disease
transmission, and undesirable immune response to the graft by the host tissue. [15,56]
1.3.2

Non-Bioloeical Implants
The implants that are composed of materials having synthetic, inorganic or non-

biological origin are categorized as non-biological implants. The non-biological
orthopedic and orthodontic implants are metal implants and polymer implants. Their
nature and limitations are described in detail below.
1.3.2.1

Metal implants. The most commonly used metals or metal alloys for implants

are stainless steel, vitallium (cobalt - chromium alloy), and titanium. [28] Due to
corrosion after implantation, stainless steel has been replaced by vitallium and titanium.
[28] In the recent years, titanium has become a popular choice as metal implant
material. Titanium implants are made of either pure titanium or as an alloy of titanium
with vanadium and aluminum.
While titanium as an implant material has virtues such as good osteointegration
compared to other metals, is less corrosive because of the oxide layer forming on the
surface of the metal, and produces less scatter during Computational Tomography Scan
(CT Scan) and Magnetic Resonance Imaging (MRI), recently it has been linked with
undesirable immune response in some patients. [53] Titanium implants also have high
failure rates due to post-surgical infections. [49]
1.3.2.2

Polymer implants. Polymer implants are used widely for both bone and soft

tissue reconstruction. [19] Polymers are long chains of repeating monomers forming
macromolecules attaining high molecular weights. The most commonly used
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biomaterial polymers are polymethylmethacrylate, silicone, polyethylene,
polypropylene, nylon, and poly-e-caprolactone. [19]
Silastic implants (elastic silicone implants) have severe side effects like capsule
formation and contracture. [19,43] Silicone implants in arthroplasty cause silicone
synovitis. [43] Complications related to polymethylmethacrylate are cause by the high
setting temperatures and an exothermic reaction, which leads to bone necrosis.
Polymethylmethacrylate can also cause tissue toxicity due to the presence of unbound
monomer, methyl methacrylate. [27] Other polymer materials lack the tensile and
compressive strength o f the natural tissue and do not integrate well with the tissue. [30]

1.4

Clinical Need for Improved Implant Materials

Drawbacks in commercially available metal implant materials range from mild
immune reactions, such as allergies, to more severe consequences, such as bone
resorption. [49, 53] Commercially available polymers need significant improvements
with respect to their tissue integration potential and mechanical properties. [27,30,43]
Implant materials are needed that are tissue integrative, biodegradable,
immunocompatible, and similar in mechanical properties to the natural tissue. These
implants should help the regeneration of the damaged tissue and should either exist in the
body inertly after the healing process is complete or should be resorbed in the body as
non-toxic or excreted out.

CHAPTER 2
TISSUE ENGINEERING AND ENHANCED MATERIALS IN
REGENERATIVE MEDICINE
Tissue engineering is an emerging field that combines the use o f cells,
engineering, and materials along with suitable biochemical and physicochemical cues to
improve or replace the biological functions. [32] Natural tissues require a specific
biological and mechanical structure to perform their regular functions. Due to either
injury or organic failure the natural tissue might lose its structural integrity and fail to
perform its natural function. [32] Tissue engineering attempts to regenerate the damaged
tissue and restore its functionality.
The term regenerative medicine even though used in relation to tissue engineering
is focused on the use o f the stem cells or progenitor cells to repair or replace the damaged
tissue. [2,32] The damaged tissue is repaired using a scaffold based approach. [2, 32] A
suitable biomaterial is selected and seeded with either differentiated cells, stem cells or
progenitor cells. These cells are guided by mechanical and /or biochemical signals. Once
die cells adhere to and populate the scaffold under the influence of mechanical andor
biochemical signals, they differentiate and produce the extracellular matrix. Depending
on the type o f the cells and tissue, the cells will produce the marker molecules and
regenerate the damaged tissue. [2,32,54]
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Bone injuries, as discussed in the earlier chapter, are commonly referred to as
fractures. Depending upon the severity of the injury and patient physiology, the treatment
may involve simple and common procedures like immobilization of the bone by
application o f casts or surgical procedures to fix the bone internally using metal plates
and screws. [4, 5, 17] Commercially available materials used for the fixative and
reparative bone surgeries have drawbacks that are discussed in detail in the previous
chapter. [24] Recent advances in the field of tissue engineering and regenerative
medicine have made it possible to design bioactive polymers that bridge the gap between
natural tissue and artificial implant materials. [2, 32, 54] These polymers can be either o f
natural, synthetic or composite in origin. By applying engineering principles and
modifying the material properties o f these implant materials we can incorporate bioactive
molecules in their mesh networks. [54] This approach can be used for in situ delivery of
the bioactive molecules reducing the risks to other systemic organs.
Depending on their design and the placement of the cells, the enhanced and
engineered biomaterials can then be used either as an assistive tool for the body’s natural
regenerative process to accelerate the healing of injury, or to compensate for the loss of
regenerative potential due to compromised physiology. These biomaterials can also be
used to improve the performance o f the implants. The biomaterials should have good
osteointegration and osteoconduction for the implant to succeed. These materials also
should possess mechanical strength comparable to the native tissue.
Most of the polymers that are used for bone tissue regeneration lack material
strength and the metal implants lack the porosity and osteointegrative properties. If the
polymer composites are used in combination with metal implants, both the materials can
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compensate for the missing properties. Addition of nanoparticles for sustained delivery of
bioactive molecules and surface modification can make the bioengineered scaffolds
desirable to the cells. With modified surface properties and secretion of bioactive
molecules the new nanoenhanced composites hold promise to fulfill at least some of the
important criteria o f good implant materials.

2.1

Rationale Behind the Three Integrated Projects

This chapter describes the three integrated and interrelated projects that focus on
the repair of the damaged bone tissue by applying principles of tissue engineering and
regenerative medicine. The interrelated projects make use of the enhanced bioactive
scaffolds as a base or a template for the progenitor cells to lay a foundation of new tissue
to replace the damaged bone tissue. In these projects, hydrogels were made from natural
organic and inorganic substances through polymer crosslinking. These hydrogels
enhanced with nanoparticles were used as in situ delivery vehicles for the bioactive
molecules.
The nanoparticles, namely halloysites, would contain the bioactive molecule of
choice. Since the bioactive molecules would be contained inside the nanoparticles and
hydrogels would hold the nanoparticles in their mesh network, the release would be
sustained and extended when compared to the release from the hydrogels alone. With this
scheme o f design, the hydrogels can be modified for their function by changing the
bioactive molecule loaded inside the halloysites.
If the progenitor cells are the target, growth factors like BMP 2,4, and 6 can be
used to improve the cellular response of the cells encapsulated in the hydrogel mesh
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network. This design can be used to deliver cells with a package o f boosters for
differentiation at the site of injury.
The construct with the progenitor cells encapsulated in the hydrogels would aid
the damaged tissue which might have lost its potential for repair if the body has
compromised physiology. If the objective is to attract the stem and progenitor cells to the
site o f injury, the hydrogels enhanced with growth factor loaded halloysites can be used.
The secreted growth factors would act as a biochemical signal to attract the cells to the
site o f injury. The nanoenhanced hydrogels can be used to coat the surface of metal
implants especially titanium, to improve cellular response, integration into host tissue,
and to prevent microbial growth on the implant surface. The titanium metal surface can
be modified by anodization to increase its surface roughness and to improve the
osteogenic response. Figure 2-1 illustrates the rationale behind the three interrelated
projects. Sections 2.2,2.3, and 2.4 describe the projects in detail.
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Figure 2-1. Graphical representation o f the rationale behind the three interrelated
projects. [10,11]
2.2

Nanoenhanced Bioactive Hydrogels

The term hydrogel was used in 1894 for the first time in literature. [42] Hydrogels
are made of network o f polymer chains that are hydrophilic in nature, hydrogels have
water as their dispersion medium and 90% of their weight is water. [41] This property of
hydrogels makes them very flexible and similar to natural tissue. [41] Hydrogels are
commonly used as scaffold materials in tissue engineering. The mesh network of the
hydrogels mimics the 3D environment of the natural tissue making them ideal for cellular
growth and response. [41, 55]
Hydrogels can be made from natural or synthetic materials depending on the
application. In tissue engineering, both the natural as well as synthetic materials are used
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for making hydrogels, e.g. natural materials like alginic acid, chitosan, hyaluronic acid,
collagen, agarose and synthetic materials like polyvinyl alcohol, polyacrylamides,
silicone, etc. [41, 55]
In the first o f the three interrelated projects, hydrogels were made from natural
and synthetic materials through polymer crosslinking. The materials used were alginate,
chitosan and calcium phosphate. Alginate and chitosan are FDA approved and biphasic
calcium phosphate is commonly used as an alternative in bone grafts. The hydrogels
contained embedded halloysites doped with bone morphogenic proteins.
Previous work on alginate-HNT scaffolds doped with BMP 2 showed promising
results using the cell line ATCC 7F2 CRL 12557 mouse osteoblasts. The work was
continued with BMP 4 and 6 loaded HNTs on the cell line ATCC 7F2 CRL 12557 mouse
osteoblasts. The cell lines, ATCC CRL 2593 MC3T3 El subclone 4, a mouse pre
osteoblast cell line and ATCC CRL 2623, a mouse mesenchymal stromal cell line were
also tested on the hydrogels with BMP 2 loaded halloysites. The composite hydrogels
composed of alginate-chitosan and alginate-calcium phosphate were tested for their
biological and mechanical properties. These nanoenhanced bioactive hydrogels can find
application in implant coatings as well as stand-alone filler materials for bone
regeneration. Figure 2-2 shows the graphical representation of the concept of the
nanoenhanced bioactive hydrogels.
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2.3

Nanoseeds

The objective of this study was to investigate the potential o f BMP 2 loaded into
halloysites as a chemoattractant agent to actively recruit cells into the damaged tissue and
thus advance tissue healing and repair. The principal goal of this research was to develop
a novel nanocomposite, a Nanoseed composed of halloysite clay nanotubes (HNTs)
nanoparticle composites, doped with osteogenic chemoattractants and inserted within
biocompatible hydrogels (alginate, calcium phosphate or chitosan). The hydrogel
construct was termed a Nanoseed because of the nanotubes that were incorporated into
the hydrogels’ mesh network. Nanoseeds, containing the chemoattractant BMP 2 loaded
HNTs, were placed on the collagen gel matrix with bone progenitor cell reservoirs. These
constructs were then assessed for their ability to actively recmit osteoprogenitor cells to
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produce a bone matrix. The experimental design and the concept of Nanoseed are
illustrated in Figure 2-3.

Figure 2-3. The experimental design and the concept of Nanoseed.

2.4

Hydrogel Biocoatings for Titanium Implants

Post-surgical infections are a major reason for the metal implant failures. [20]
Titanium, a favored choice for metal implants, faces the problem of bacterial biofilm
formation leading to its failure. [37] There are studies on coating the surfaces of the metal
implants with anti-microbial coatings, but these coatings could not prevent the formation
o f bacterial film. [26] The major reason for the failure of anti-microbial coatings is the
failure to release the anti-microbial drugs in a controlled and sustained manner. [26, 39,
52] The coatings either broke down early in the body’s internal environment or failed to
release the drug. [39, 52]
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In the hydrogel biocoating project, there are two major goals: the first is to
prevent the formation o f bacterial films and the second is to make the surface of the
titanium favorable to the bone cells for attachment and proliferation. Calcium phosphate
bone cement has been used in combination with alginate and chitosan and enhanced these
hydrogels with anti-microbial agent loaded halloysites. Gentamicin Sulfate (GS) was
used as the anti-microbial agent because of its heat stability, wide use in the orthopedic
surgeries and its effectiveness against the gram negative strains of bacteria. [8,38] To
achieve better surface for cellular response, the titanium surface was modified by
anodization.
The hydrogel biocoatings were tested for their effectiveness in achieving a
controlled and sustained release of the drug as well as their ability to inhibit the
bacterium. Anodization was done by acid etching using Hydrofluoric acid (HF) as the
electrolyte. The surface morphology of the anodized titanium was studied by scanning
electron microscopy. The anodized titanium was also tested to check if it retained its
osteogenicity by examining the deposition of hydroxyapatite crystals by treating it with
simulated body fluid. The graphical representation of the concept of hydrogel coatings
for anodized titanium is shown in the Figure 2-4.
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2.5

Objectives of the Projects

The basic objective o f all the three projects is to design scaffolds that are
cytocompatible, tissue integrative, tissue conductive, and would resemble native tissue in
their material properties. The detailed objectives of the individual projects are listed
below:
1. To design bioactive enhanced hydrogels with growth factor molecules loaded in
them to improve the cellular response and surface morphology.
2. To obtain a sustained and extended release of growth factors and anti-infectives
from the nanoparticles and hydrogels enhanced with nanoparticles.
3. To check the surface and other material properties of the hydrogels enhanced with
nanoparticles.
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4. To investigate if the nanoenhanced hydrogels act as a chemoattractant to the
progenitor cells.
5. To anodize titanium and investigate its surface properties with respect to
osteogenicity.
6. To design anti-infective hydrogels that would inhibit microbial growth and can be
used to coat anodize titanium.

CHAPTER 3
INSTRUMENTATION AND METHODS
The current chapter details the instrumentation and methods used for scaffold
preparation, material characterization of the scaffolds, and the response o f different cell
types to the scaffolds.

3.1

Instruments

Instruments form an important means of investigating a variety of scaffold
properties. The following subsections detail the instruments used in the current
dissertation. The instruments and the types of data they produced are detailed below.
3.1.1

HITACHI S 4800 Field Emission-Scanning Electron
Microscope and EDX
HITACHI S 4800 Scanning Electron Microscope (FE-SEM) was used to image

the hydrogel and titanium metal surfaces. The high magnification attained by the FESEM allowed a close comparison of the surface morphologies of the hydrogels and
titanium (anodized and non-anodized). This comparison helped in the assessment of the
surface properties and in predicting the behavior o f the scaffolds in simulated body
conditions. Figure 3-1 shows HITACHI S 4800 FE-SEM at the Institute of
Micromanufacturing, Louisiana Tech University, Ruston (IfM).
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Figure 3-1. HITACHI S 4800 FE-SEM at Institute of Micromanufacturing, Louisiana
Tech University. [12]
3.1.2

NOVA e2000 B. E. T. Surface Area and Pore Size Analyzer
Brunnauer-Emmett-Teller or B. E. T Surface Area and Pore Size analysis works

on the principle of physical adsorption of gas molecules on the surface o f solid materials.
[31 ] This theory by Brunnauer-Emmett-Teller is based on the Langmuir theory which
assumes that the adsorbate, in this case an inert gas, behaves as an ideal gas under
isothermal conditions and its partial pressure is directly proportional to its volume
adsorbed on the solid surface. [31,40]
NOVA e2000 Surface Area and Pore Size Analyzer works on the B. E. T.
principle and can measure surface area and pore size of the sample using the helium void
volume method. For our hydrogel samples, we have used the Langmuir method of
plotting the isotherm. But the instrument, NOVA e2000, can perform other types of
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computational analyses such as V-t method, DR method, etc. Figure 3-2 shows NOVA
e2000 Surface Area and Pore Size Analyzer at IfM.
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Figure 3-2. NOVA e2000 Surface Area and Pore Size Analyzer at Institute of
Micrmanufacturing, Louisiana Tech University. [1]
3.1.3

NANODROP 2000 Spectrophotometer
NANODROP 2000 from Thermo Scientific is a UV-VIS spectrophotometer

which uses only 1 pi of the sample for DNA, RNA, Protein, and other assays for
biochemical analyses. This instrument also analyzes the samples within few minutes.
Either a cuvette (for dilute samples) or the pedestal can be used for the analyses of the
samples and the results can be obtained in the form of graphs on the software that is
linked to the instrument. [6]
NANODROP 2000 spectrophotometer was used to measure the samples from the
release study samples as well as the histochemical analyses. NANODROP 2000 used for
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this research was located in the common second floor lab in the Biomedical Engineering
building, Louisiana Tech University. Figure 3-3 shows Thermo Scientific NANODROP
2000 spectrophotometer.

Figure 3-3. Thermo Scientific NANODROP 2000 spectrophotometer
3.1.4

Olympus BX51 Fluorescent Microscope
The Olympus BX51 fluorescent microscope images cells live or in the fixed state.

It has filters for different fluorescent dyes such as DAPI, Alexa Fluor Red, FITC, and
TRITC. This microscope can also image the cells in phase contrast mode when the UV
lamp is turned off. The images are captured in high definition and can be taken at 10X,
20X or 40X magnifications.
For visualizing the cells stained with different histochemical stains and
fluorescent dyes we used 10X and 20X magnifications. The scaffolds and the seeded cells
were also imaged on the phase contrast mode. Figure 3-4 shows Olympus BX51
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epifluorescence microscope in the microscopy lab in the Biomedical Engineering
Building.

Figure 3-4. Olympus BX51 epifluorescence microscope in BME microscopy lab,
Louisiana Tech University.
3.1.5

LABCONCO Lvoohilizer
Lyophilizer freeze dries the samples under low temperature and vacuum. This

method of drying preserves most of the structural details of the samples, especially,
hydrogels. For electron microscopy, the samples need to be dry and if hydrogels are dried
under vacuum at room temperature their structure collapses turning the hydrogel beads
into powder. Lyophilizer uses temperatures as low as —20 °C retaining the structural
features while at the same time drying the samples.
The hydrogel samples were frozen at - 2 0 °C overnight and then subjected to
vacuum conditions in the LABCONCO lyophilizer. The process was carried out for 36
hours. The samples obtained were stored at room temperature under dry conditions.
Figure 3-5 shows the LABCONCO lyophilizer located in Biomedical Engineering
building Room 151.
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Figure 3-5. LABCONCO lyophilizer in BME 151, Louisiana Tech University.
3.1.6

Absorbance Microplate Reader
The principle o f absorbance microplate reader is similar to that of

spectrophotometer the only difference being the stage on which the samples are mounted
for analyses. Absorbance microplate reader utilizes a stage that can read 96 well plates or
similar plates that are used for cell culture and ELISA studies.
For the quantification o f released bioactive molecules in the release profile studies
using ELISA, Phenix LT-4000 absorbance microplate reader was used. The assays were
done in a 96 well plate specially treated for ELISA. Figure 3-6 shows Phenix LT-4000
absorbance microplate reader in Biomedical Engineering building Room 238.

27

n P h en ix

Figure 3-6: Phenix LT-4000 absoibance microplate reader in BME 238, Louisiana Tech
University.
3.1.7

Anodization Set-Up
Anodization uses the metal to be coated and etched as an anode. The method used

in this research for etching on the surface of titanium is acid etching. Hydrofluoric Acid
(HA) was used as an etchant and titanium metal sheet (polished manually with alumina)
was used as an anode. Oure platinum electrode was used as cathode. A voltage of 1 V
was applied with a current of 10 amps. Figure 3-7 shows the anodization set up in
Carson-Taylor Hall Room 316.
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Figure 3-7. Anodization set-up at Carson-Taylor Hall room 316, Louisiana Tech
University.
3.2

Methods

Detailed in the following sub-sections are the methods used to construct the
scaffolds, prepare samples for various analyses and biochemical assays used for
determination of the cellular response to the scaffolds.
3.2.1

Preparation of Hydrogels
Hydrogels are formed by crosslinking monomers into long interlinked polymers.

They have a mesh like network that can be attributed to the chemistry of their bonds.
Hydrogels can hold large amounts of water molecules in their structure giving them their
name.
In current research, calcium alginate hydrogel forms the base o f all the hydrogel
composites. Sodium alginate 2% w/v was reverse crosslinked with 1% w/v calcium
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chloride. The hydrogel composites consisted of the following materials in specific
concentrations are shown in Table 1.
Table 1: Materials in specific concentrations used for hydrogel composites
Alginate
Only

2% w/v
sodium
alginate

1% w/v
calcium
chloride

Alginate +
HNTs

2% w/v
sodium
alginate

1% w/v
calcium
chloride

Alginate +
TTCP

2% w/v
sodium
alginate

1% w/v
calcium
chloride

Alginate +
TTCP +
HNTs

2% w/v
sodium
alginate

1% w/v
calcium
chloride

Alginate +
TTCP +
Chitosan

2% w/v
sodium
alginate

1% w/v
calcium
chloride

Alginate+
TTCP +
Chitosan +
HNTs

2% w/v
sodium
alginate

1% w/v
calcium
chloride

3.2.2

1% w/v
HNTs

0.33 gm TTCP
per 1 ml
alginate
solution
1% w/v
HNTs

1% w/v
HNTs

0.33 gm TTCP
per 1 ml
alginate
solution
0.167 gm
TTCP per 1 ml
alginate
solution

3.33 mg
Chitosan
lactate per 1
ml alginate
solution

0.167 gm
TTCP per 1
ml alginate
solution

3.33 mg
Chitosan
lactate per 1
ml alginate
solution

Vacuum Loading of Hallovsite
HNTs were loaded with bioactive molecules like growth factors and anti

microbial agents. The basic process of vacuum loading remained the same, with the
concentrations differing according to the molecule o f interest. For sterilizing them, the

HNTs were spread onto a parchment paper piece and kept under the UV light for 45
minutes. Throughout the loading process aseptic conditions were maintained.
3.2.2.1

Loadine HNTs with Growth Factors. Bone Morphogenetic Proteins 2 ,4 , and

6 were obtained from ProSpec Militany, Tel Aviv, Israel. A stock solution o f the
respective growth factors was prepared as per the manufacturer’s instructions. A
dilution o f the concentration 10 pg/ml was prepared from the stock solution for all the
three growth factors. All the solutions were made from sterile diluents and under
aseptic conditions.
After sterilization under the UV light, the HNTs were sonicated for 15 minutes
with the prepared growth factor solutions. The final concentration of HNTs to the growth
factor solution is 50 mg HNTs in 10 ml of 10 pg/ ml growth factor solution. This solution
was then kept in vacuum chamber under sterile conditions for 24 hours with intermittent
vacuum applied to it. After 24 hours, the HNTs were separated by centrifugation and then
washed in distilled water to remove traces o f growth factors sticking on the outer surface
of the tubes. After washing, the loaded HNTs were dried in vacuum and stored at 4 °C.
3.2.2.2

Loadine HNTs with Anti-Microbial Aeent. The anti-microbial agent used in

the current research, Gentamicin Sulfate (GS), was obtained from Sigma-Aldrich, St.
Louis, MO. A solution o f 60 mg/ ml was prepared in autoclaved water. To the 10 ml of
60 mg/ml solution o f GS 50 mg HNTs were added and sonicated for 15 minutes under
sterile conditions. This solution was then kept in vacuum chamber under sterile
conditions for 24 hours with intermittent vacuum applied to it. After 24 horns, the
HNTs were separated by centrifugation and then washed in distilled water to remove
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traces of growth factors sticking on the outer surface o f the tubes. After washing, the
loaded HNTs were dried in vacuum and stored at 4 °C.
3.2.3

Sample Preparation for FE-SEM
Lyophilization is a process where the sample is subjected to rapid drying under

frigid and vacuum conditions. This is done to retain the structural details but to remove
water molecules from the sample. FE-SEM requires the samples to be dry to obtain high
magnification and high resolution images.
To lyophilize, the hydrogels were subjected to -20 °C temperature overnight
before starting the process. This prevents the hydrogel structure and pores from
collapsing under extreme low pressure. After freezing the samples, they were attached to
the docks provided for the glass beaker and the vacuum was started. The process usually
completes in 24 hours but the samples were kept running in the lyophilizer for 36 hours
to ensure that they have no moisture.
3.2.4

Coating 12 Well Plates with Collagen Type I Gels
The cell migration experiments in the project ‘Nanoseeds’ required a gel matrix to

hold the hydrogel constructs in place away from the cell reservoir. Collagen type I gel
was the best suited option as it is the basic component of any tissue’s extra cellular
matrix. This gel would mimic the conditions found in the natural tissue. The cell culture
12 well plates were coated with collagen type I to obtain the gel matrix.
Rat tail type I collagen was obtained from GIBCO, Life Technologies and the
collagen gel was prepared as per the procedure and formulae provided by the
manufacturer.
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3.2.5

Cell Assays
Biochemical assays quantify the cellular response to the scaffolds and in turn can

give us an idea about how the scaffolds behave in vitro.
3.2.5.1

Trypan Blue Cell Count for Seedim Density. To fix the concentration of

seeding the cells on to the scaffolds, we needed to quantify the number of cells in one
T25 cell culture flask at 80% confluence. To calculate the amount of cells present in the
flask, Trypan Blue cell viability method was used.
Cell suspension (1 ml) was taken from a passage 2,80% confluent T25 flask and
0.1 ml o f 0.4 % v/v Trypan Blue solution was added to it. A hemocytometer was used to
determine the number of live and dead cells. If the cells take up the dye, they are nonviable and vice versa. Under a 10 X magnification o f the light microscope, the total
number of cells and number of blue cells are counted in a hemocytometer. The number of
viable cells is calculated as follows:
% viable cells = [1.00 - (No. of Blue Cells / Total number of cells)] X 100
Cells/ ml cell suspension = No. of Viable cells X 104 X 1.1
3.2.5.2

NucBlue Fluorescent Stainine. NucBlue Live Ready Probes fluorescent stain,

Life Technologies, Thermo Fisher (Grand Island, NY) works on the same principle as
the DAPI stain. It is a cell permeant nuclear dye that emits blue fluorescence when
bound to the DNA. The staining procedure was carried out as per the manufacturer’s
instructions. Three drops of the dye were added per ml of the cell suspension and
incubated for 20 minutes protected from the light. The cells were visualized under
Olympus fluorescence microscope under the DAPI filter.
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Results are not shown in Section 5.3 as the dye faded after Day 3 and the Days
1 and 3 figures were not sufficient to suggest the migration of cells form the cell
reservoir towards hydrogel ‘Nanoseeds’. The histochemical staining with Alcian Blue
and Von Kossa were more conclusive to show the migration and differentiation of the
cells towards the hydrogel ‘Nanoseeds’.
3.2.5.3

Alcian Blue Stainin2 . Alcian Blue stains the acidic mucopolysaccharides of

the ECM blue and helps to visualize the otherwise fuzzy ECM. This assay helps to
assess the ECM production on the scaffolds or in response to them.
The fixed cells or the constructs with the cells were washed with HBSS and
then stained with 0.5%v/v Alcian Blue stain from Electron Microscopy Inc. for 20
minutes. The cells and the constructs were visualized under 10 and 20 X magnification
of Olympus Light microscope.
3.2.5.4

Picrosirius Red Stainine. Picrosirius Red stain helps to visualize the

collagen secretion by the cells when they are forming ECM. Collagen, especially type I,
is a major component o f ECM of a majority of the tissues in the body. Picrosirius Red
stains collagen red, revealing the extent o f ECM production and differentiation of the
cells.
The fixed cells or the constructs with the cells were washed with HBSS and
then stained with Picrosirius Red, Polysciences Inc. (Warrington, PA) solution A for
two minutes and then in solution B for 60 minutes. After 60 minutes, solution B was
removed and solution C was added and kept for two minutes. After the staining was
completed, the excess stain was washed with distilled water. The collagen secretion
was visualized under Olympus light microscope at 10 and 20 X magnification.
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3.2.5.5

Von Kossa Stainine. Von Kossa stain utilizes the reaction between 3% v/v

silver nitrate solution and the phosphate group of calcium phosphate or hydroxyapatite
molecules to visualize the calcium phosphate synthesis by the cells after differentiation.
Bone progenitor cells produce calcium phosphate as a result of differentiating into the
mature osteocytes. Calcium phosphate is the major inorganic content o f bone.
The fixed cells or the constructs with the cells were washed with HBSS and
then 3% v/v silver nitrate solution from Polysciences Inc. (Warrington, PA) was added
to the wells. The solution and the constructs were the placed under UV light for 15
minutes. After 15 minutes, the solution was discarded and the constructs washed with
distilled water twice and 5% v/v sodium thiosulfate solution was added to the
constructs to remove traces of unreacted silver nitrate. The constructs were then washed
with distilled water twice. The black or brown stained phosphate deposits were
visualized under Olympus BX51 brightfield microscope at 10 or 20X magnification.
3.2.6

Release Profile Study
The release profiles of bioactive agents were studied in simulated physiological

conditions. Release profiles o f the bioactive molecules were obtained from both loaded
HNTS and hydrogels enhanced with loaded HNTs. The loaded HNTs or the hydrogel
beads enhanced with loaded HNTs were suspended in sterile Hank’s Balanced Salt
Solution (HBSS) and put on a rocker platform for uniform agitation. Samples were taken
and stored in sterile tubes at 4 °C for further analysis. All the release profile experiments
were performed at room temperature.
For growth factor release profile (BMP 2), the samples were collected at 24 hours
and 7 days. The concentration was determined by performing ELISA on the stored
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samples. The samples were brought to room temperature before performing the assay.
The ELISA kits were custom made Quantikine kits for BMP 2 and obtained from R&D
systems (Minneapolis, MN). The readings were taken on the absorbance plate reader. The
concentration o f the released BMP 2 at a particular time point was estimated by plotting
standard curves o f the known BMP 2 standards and finding the corresponding values of
the concentration for a particular optical density reading.
The release profile for GS was carried out using similar method of agitation and
sample collection. The samples were collected at 24 and 36 hours and stored at 4 °C. The
method for estimating the concentration was OPTA colorimetric analysis. The readings
were taken on UV/VIS NANODROP spectrophotometer. The concentration o f released
GS was estimated by plotting standard curves of known concentration standards of GS
and finding the corresponding values of the concentration for a particular optical density
reading.
3.2.7

Bacterial Inhibition Study
Bacterial inhibition study was done to assess the efficiency o f GS when loaded in

HNTs and encapsulated in hydrogels. Muller-Hinton LB agar plates were prepared as per
the standard procedure and aseptic conditions were maintained throughout the study.
DH5a strain of E. coli was used to study the effect of anti-infective agent by studying the
formation o f growth inhibition zone on the agar plates. A negative control plate had a
lawn o f bacteria growing without any anti-infective agent. Positive control plate had GS
standard disc placed on the bacterial culture. The experimental plates had different
compositions of hydrogels with and without the anti-infective agent GS. The study was

36
conducted for 24 hours and the plates checked for the formation growth inhibition zones
around the hydrogel constructs indicating the effectiveness of the anti-infective agent.

CHAPTER 4
NANOENHANCED BIOACTIVE HYDROGELS
4.1

Introduction

In the field of regenerative medicine, research efforts are directed at the
development of scaffolds that are biocompatible and that assist in the body’s native
regenerative response. Hydrogels are a commonly used scaffold. Hydrogels have been
used extensively to deliver a wide variety of bioactive agents. [41, 55] Alginate is a FDA
approved material, commonly used in drug delivery, cell and enzyme encapsulation. [13,
58] One o f the challenges faced by the hydrogels is the release o f biomolecules in
extremely low amounts and in a sustained manner. [58]
To achieve this objective, the HNTs were loaded with growth factors like BMP 2,
4 and 6. HNTs are cylindrical in their structure with concentric layers o f aluminosilicate
and have a lumen which is charged. [7] This unique structure of the HNTs makes them
suitable for loading a variety o f charged molecules. [22] Previous studies on the HNTs
have shown that they can be used to deliver bioactive molecules like anti-infective
agents, proteins, etc. in a sustained manner. [22,29]
The hypothesis of this project was that HNTs would provide a sustained release of
the growth factors and would improve the material and biological properties of the
calcium alginate hydrogels.
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4.2

M aterials and Methods

All the plastic wares, such as, syringes, centrifuge tubes, microcentrifuge tubes,
12 well plates, pipettes, etc. were purchased from Mid Scientific, St. Louis, MO. Cell
culture media, buffers, and serum were purchased from Life Technologies, Grand Island,
NY. Sodium citrate, sodium chloride, calcium chloride, sodium alginate, and HNTs were
obtained from Sigma-Aldrich, St. Louis, MO. BMPs (BMP 2,4, and 6) were purchased
from Prospec (Rehovat, Israel). Preosteoblast cell line MC3T3 subclone El (ATCC CRL
2593) was obtained from ATCC, Manassas, VA. BMP 2 Quantikine ELISA Kit was
obtained from R&D Systems, MN.
4.2.1

Cell Culture. Cell Seeding and Preparation of the Constructs
Preosteoblast cell line was the model used to study in vitro cellular response to the

nanoenhanced hydrogels. This cell line exhibits osteoblast differentiation once supplied
with ascoibic acid and after differentiation their behavior is similar to that of the calvarial
osteoblasts. [50] Standard aseptic cell culture protocols were followed to proliferate,
passage and dissociate the cells in sterile cell culture grade plasticware.
For encapsulation, after detaching them from the flasks, the cells were suspended
in Sterile HBSS. After centrifugation, the cell pellet was isolated and then resuspended in
fresh HBSS. The seeding density was determined by hemocytometer and tryphan blue
solution. The procedure is described briefly in Section 3.2.5.1. The seeding density used
was 1 X 106cells/bead.
For preparation o f the hydrogel beads, all the solutions, such as, 2% w/v sodium
alginate, 1% w/v calcium chloride, and HNTs (before loading) were sterilized. The HNTs
were sterilized under UV for 45 minutes and the solutions were prepared in autoclaved
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reverse osmosis (RO) water. To ensure that the solutions have no contaminants, they
were sterile filtered through 0.45 gm syringe filters. The HNTs were loaded as mentioned
in Section 3.2.2.1.
The cells that were suspended in sterile HBSS were carefully dispersed in the 2%
w/v sodium alginate solution. Cell culture plastic 24 well plates were set up with 1% w/v
calcium chloride solution. The set up comprised of five groups: control group # 1, control
group # 2, experimental group # 1: BMP 2, experimental group # 2: BMP 4, and
experimental group # 3: BMP 6. The sodium alginate+ cells solution was dropped
carefully using sterile 27-G syringes in the respective wells.
4.2.2

Sample Fixation and Histochemical Analyses
The samples were made in triplicates and the experiment was performed twice to

check for the reproducibility of results. The hydrogels were formed instantaneously but
the beads were kept in the calcium chloride solution for about 15 minutes to ensure
complete gelation. After 15 minutes, the beads were washed twice with sterile HBSS and
complete a-MEM was added as the growth medium for the cells.
The samples were fixed on days 0, 1,3,7, 14, and 21 and biochemical and
histochemical analyses were performed. The detailed procedures for Alcian Blue,
Picrosirius Red, and Von Kossa Staining are provided in Sections 3.2.5.3, 3.2.5.4, and
3.2.5.5, respectively.
4.2.3

Release Profile Study for BMP 2
Release profile study for BMP 2 was done to understand the elution of the protein

from HNTs. As the amount of the protein that would be eluted fell in the ranges of
nanograms and pictograms, custom made ELISA kits were used. The Quantikine ELISA
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kits from R&D systems can estimate the amount o f BMP 2 as low as 50 picograms. The
details o f the sample collection and overall procedure are provided in the Section 3.2.6.
4.2.4

FE-SEM Imagine and Material Testing
To visualize if the addition o f HNTs had any effect on the surface morphology of

Ae hydrogels, FE-SEM imaging was performed on lyophilized hydrogel samples. The
Lyophilization protocol is detailed in Section 3.2.3.
The material properties such as porosity, and surface area were analyzed using
BET method. The sample preparation was simple for BET Surface area and pore size
analyzer (NOVA e2000). The hydrogels were dried on Whatman No. 1 filter paper till the
excess water was drained. After partial drying, the initial weights of sample (respective
hydrogel types) were recorded. The degassing step was skipped as the hydrogels char at
temperatures as high as 300 °C. Langmuir method o f plotting isotherm was used to
analyze the results. The principle behind BET NOVA e2000 surface area and pore size
analyzer is described in detail in Section 3.1.2.

4.3

Results and Discussion

This section represents the results and their discussion from the experiments
mentioned in Section 4.2.
4.3.1

Histochemical Analysis
The results o f histochemical analysis of the hydrogels enhanced with BMP 2,4,

and 6 were compared to the previously obtained histochemical analysis results of the
hydrogels enhanced with BMP 2 loaded HNTs from the thesis, Bioactive Hydrogels for
TMJ Repair. [29] The comparison was done to investigate the potential of HNTs loaded
with growth factors as an m situ drug delivery vehicle and also to test the primary

hypothesis of this project, that is, the addition o f growth factor loaded HNTs improves
the biological and material properties of hydrogels.
4.3.1.1

Alcian Blue stainine. The Alcian Blue assay was performed to visualize the

amount of acidic ECM mucopolysaccharides. Alcian Blue stains the acidic
mucopolysaccharides, found in the extracellular matrix produced by the differentiating
cells, blue indicating the extent of ECM production. Figures 4-1 to 4-4 show Alcian
Blue staining o f the alginate hydrogels enhanced with BMP 2,4, and 6 loaded HNTs
with osteoblasts encapsulated in them. Figure 4-1 (A-F) shows Day 0 Alcian Blue
staining o f the alginate hydrogels with BMP 2,4, and 6 loaded HNTs. The Alcian Blue
staining was performed on fixed hydrogel beads on days 0 ,1 ,3 , 7,14, and 21. The
figures are representative and only days 0 ,7 ,1 4 and 21 are shown in this dissertation as
they show the progression o f ECM production after cellular differentiation in the
different experimental groups of hydrogels with growth factors and HNTs.
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Figure 4-1. Alcian Blue staining Day 0 A) Control 1 Alginate-only B) Control 2 Alginate
+ HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 Alginate+
HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+ BMP 4 F)
Experimental 4 Alginate+ HNTs+ BMP 6.
In Figure 4-1, A) and B) are controls with alginate hydrogels without HNTs as in
A and without growth factors as in B. Figures 4-1 C), D), E), and F) show alginate+
HNTs+ BMP 2, alginate+ HNTs+ BMP 2 with 0.4 M ascorbate added to the medium,
alginate+ HNTs+ BMP 4 and alginate+ HNTs+ BMP 6, respectively. Day 0 staining was
done after 8 hours o f osteoblast encapsulation with the hydrogels. The images show that
C and D have more proliferating cells as seen by the pink Hematoxylin stained nuclei.
Images E and F are comparable to the controls in A and B. No pink stained masses were
visible in the images A, B, E, and F. This suggests that proliferation was slower in these
hydrogels as compared to the images in C and D after 8 hours of cell encapsulation.
Figure 4-2 (A-F) shows Alcian Blue on Day 7.

43

Figure 4-2. Alcian Blue staining Day 7 A) Control 1 Alginate-only B) Control 2 Alginate
+ HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2 Alginate+
HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+ BMP 4 F)
Experimental 4 Alginate+ HNTs+ BMP 6.
In Figure 4-2, controls A and B show less to no deep stained islands or patches of
differentiated cells. The staining looks lighter in the controls A and B unlike the
experimental groups (C-F). Experimental groups #1 and #2 (C and D) show pink and
blue areas with deep pink stained islands or patches of differentiating cells shown by the
arrows. Experimental groups #3 and #4 (E and F) show deeply stained hydrogels
suggesting that the ECM produced was more and evenly spread than the rest of groups. E
and F also show some dark pink spots or deeply stained patches which are cells
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concentrated in these areas shown by arrows. A comparison of the images, C, D, E, and F
with the controls A and B, suggests that the experimental groups performed better with
respect to the ECM production (which is suggestive of cellular differentiation) by Day 7.
The images E and F when compared to C and D show prominent dark patches of cells
surrounded by ECM mucopolysachharides that is evenly spread throughout the hydrogels
suggesting that experimental groups #3 and #4 performed better with to respect to ECM
production than experimental groups #1 and #2. Figure 4-3 (A-F) shows Alcian Blue
staining on Day 14.

t

Figure 4-3. Alcian Blue staining Day 14 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
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In Figure 4-3, controls A and B show light pink (cells) and blue regions (stained
ECM) suggesting differentiating cells surrounded by the ECM they secrete. The staining
is lighter than the experimental groups #l-#4 (images C-F). The experimental groups #1
and #2 (C and D) show dark pink patches shown by arrows (differentiating osteoblasts)
surrounded by dark blue regions of dense ECM mucopolysachharides. The experimental
groups #3 and #4 (E and F) show larger dark pink or purple patches of the differentiating
cells surrounded by dark blue stained ECM mucopolysachharides. The images in Figure
4-3 (A-F) show that even though the controls (A and B) have started showing blue
stained ECM, it is much lighter than the experimental groups #l-#4 (C-F). The
experimental groups #3 and #4 (E and F) show darker and deeper blue stained hydrogels
than the experimental #1 and #2 (C and D) suggesting more ECM is produced in these
hydrogels than the other on Day 14. Figure 4-4 (A-F) shows Alcian Blue staining on Day
21 .
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Figure 4-4. Alcian Blue staining Day 21 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
In Figure 4-4, controls A and B show deep pink or purple patches of cells
surrounded by ECM stained in blue. The experimental groups #l-#4 (C-F) show deeper
pink stained regions and dark blue stained regions of ECM as compared to the controls A
and B. The experimental groups #1 and #2 (C and D) show the dark pink or purple
regions of cells, shown by arrows, surrounded by blue colored region of ECM produced
by these cells. The experimental groups #3 and #4 (E and F) show dark patches of cells,
shown by arrows, surrounded by deep blue stained ECM. The images E and F show
hydrogels stained blue and no differentiable pink regions because the ECM
mucopolysachharides are denser than the other groups.
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If the images of the experimental groups #l-#4 (C-F) from day 0 to Day 21 are
compared, experimental groups #3 and #4 (E and F) show deep blue stained hydrogels
from day 0 to Day 21 suggesting that the hydrogels with BMP 4 and 6 loaded HNTs
perform better with respect to the early onset of ECM production by the differentiating
cells. The experimental group 2 (D) showed more deep pink patches of the cells on Day 7
and the trend continues till Day 21. The deep pink patches are surrounded by deep blue
stained regions o f ECM mucopolysachharides, well defined on days 14 and 21. This
suggests that hydrogels with BMP 2 loaded HNTs combined with 0.4 M ascorbate in
growth medium enhanced cellular proliferation and differentiation.
The control 2 with alginate+ HNTs and no growth factors (B) showed no
enhancement of cellular responses in the hydrogels on days 0 to 21 suggesting that
halloysite, alone, would not enhance the cellular responses in these hydrogels. To achieve
enhanced cellular response for nanoenhanced hydrogels, the HNTs should be loaded with
osteogenic growth factors such as the ones used in this project, namely, BMP 2 ,4, and 6.
The observations made by visual qualitative analysis of the Alcian Blue stained
sections o f hydrogels can be further ascertained by image analysis done by Image J
software. The representative images o f Controls 1 & 2 and the experimental groups E l, E
3, and E4 for days 0 and 21 are given in Figure 4-5 to 4-15. Figure 4-5 shows RGB peaks
for alginate-only hydrogel control (C l) for day 0.
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Figure 4-5. Image analysis for Alcian Blue staining Control 1 Day 0.
Figure 4-5 shows the RGB peaks for Alcian Blue staining for control 1 on day 0.
The intensity for Blue and Red is towards the value 255 which is for white color. It
implies that the Blue and Red are less intense in the given region of interest. This
supports the observation from the qualitative visual analysis o f the histological staining
earlier suggesting less cell proliferation and low ECM production in the control 1 on day
0. Figure 4-6 shows RGB peaks for alginate-only hydrogel control (C l) for Day 21.
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Figure 4-6. Image analysis for Alcian Blue staining Control 1 Day 21.
Figure 4-6 shows RGB peaks for Alcian Blue staining for control 1 on Day 21.
The intensity for Blue falls in the range between the values 0 which is for Black and 255
which is for white color. This suggests that there is some production of ECM in the
hydrogel matrix as observed in the earlier section on the histological analysis. The
intensity for red falls near black suggesting more intense red staining indicating presence
o f proliferated cells. This observation supports the observations in the previous section
suggesting that alginate-only hydrogels showed more cellular proliferation by Day 21 and
very little ECM production. Figure 4-7 shows RGB peaks for alginate + HNTs hydrogel
control (C2) for day 0.

50
i

i

AB

Ct_D0_AB; 429x277 pixtls, ROB; 464K

Red Histogram of AB

300x240 pixels; ROB; 281K

255
Count 17748
Mean: 114 648
StdDev: 10.319

Min: 94
Max: 157
Mode 106(999)

I bit I fin n y I I o n I U m I I r r b II v * * a e * U *

i

Graco Histogram of AB

Blue Histogram of A8

□

—

□

300x240 pixels; ROB: 281K

255

255
Count 17748
Mean: 174 021
StdDev 6 183

X

300x240 pixels; ROB: 281K

Count 17748
Mean: 190.266
StdDev 5 627

Min: 157
Max: 199
Mode: 169 (1335)

u.iciu.io.naai 27“;

I

Min: 174
Max: 214
Mode: 187 (1335)

-aligialisJlBl ZZ.

Figure 4-7. Image analysis for Alcian Blue staining Control 2 Day 0.
Figure 4-7 shows the RGB peaks for Alcian Blue staining for control 2 on day 0.
The red color has intensity falling midway between the values for black color (0) and
white color (255). Green and blue have intensities closer to white color suggesting a less
intense staining. This suggests that the Red color is more intense in the region of interest
suggesting more cell proliferation. This supports the observations in the previous section
that control 2 has more cell proliferation and less ECM production. Figure 4-8 shows
RGB peaks for alginate + HNTs hydrogel control (C2) for Day 21.
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Figure 4-8. Image analysis for Alcian Blue staining Control 2 Day 21.
Figure 4-8 shows Alcian Blue staining for control 2 on Day 21. The red color
shows intensity ranging over a broad range of values lying midway between the values
for black (0) and white (255). This suggests that there is increased cell proliferation seen
in the region of interest. The blue and green colors have intensity values at the midway
but more towards black. This suggests that there is slight increase in the ECM production
from day 0. This is supported by the observations in the earlier section suggesting that
when compared to control 1 and day 0 there was slight increase in ECM production in
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control 2 on Day 21. Figure 4-9 shows RGB peaks for Alginate + HNTs + BMP 2
hydrogel experimental (El) for day 0.

£

-

E1_D0.AB.jpg

o

x

1 Red Histogram ot E1.D0.AB
300x240 pixels; ROB; 281K

425x277 pixels; RGB; 460K

H
£

C ount 41760
Mean: 99 520
StdDev 19.992

Min: 48
Max: 241
Mode: 95 (969)

v»lue-141
lis t | Copy I Log I Live |RGB||
count-89
1---- 1----1---- 1

Green Hatogrw n of £1_00_AB

i

300*240 pixels; RGB; 281K

Blue Histogram of EI.DO.AB

—

O

300x240 pixels; ROB; 281K

255
C ount 41760
Mean: 112 968
StdDev: 20.735

lis t I Copy I Log

Min: 71
Max: 192
Mode: 103 (1317)

Live

RGB

Count 41760
Mean: 140.775
StdDev 21 521

Min: 81
Max: 220
Mode: 132 (1072)

list | Copy | L o g | U vo||R G 8|f

value-131
count-997

Figure 4-9. Image analysis for Alcian Blue staining Experimental 1 Day 0.
Figure 4-9 shows RGB peaks for Alcian Blue staining o f experimental 1 on day 0.
All the three colors show peaks that are well pronounced and lie slightly towards black.
This suggests that there is fair amount of cell proliferation and some ECM production in
the experimental 1 on day 0. This observation is also substantiated in the earlier section.
Figure 4-10 shows RGB peaks for alginate + HNTs + BMP 2 hydrogel experimental (El)
for Day 21.
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Figure 4-10. Image analysis for Alcian Blue staining Experimental 1 Day 21.
Figure 4-10 shows RGB peaks for Alcian Blue staining for experimental 1 on Day
21. All the three colors show broad range o f values for intensities. Especially red that
ranges from value near black (0) to white (255). This suggests that there is more cell
proliferation as well as ECM production suggested by the intense staining in red and
blue. Figure 4-11 shows RGB peaks for alginate + HNTs + BMP 4 hydrogel
experimental (E3) for day 0.
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Figure 4-11. Image analysis for Alcian Blue staining Experimental 3 Day 0.
Figure 4-11 shows RGB peaks for Alcian Blue staining for experimental 3 on day
0. There is an intense red staining suggested by the sharp red peak falling on the value 0
for black color. There is very less intense blue color suggested by the blue peak lying on
the value 255 for white color. This suggests that there is cell proliferation but little to no
ECM production. Figure 4-12 shows RGB peaks for alginate + HNTs + BMP 4 hydrogel
experimental (E3) for Day 21.
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Figure 4-12. Image analysis for Alcian Blue staining Experimental 3 Day 21.
Figure 4-12 shows RGB peaks for Alcian Blue staining for experimental 3 on Day
21. As seen in the graph for red color the peak shows intense red staining suggesting a
high cell proliferation. The blue color also has intensity increased from day 0 suggesting
increased ECM production. These observations are supported by the observations made
in the previous section that the ECM production increased as the days progressed in
experimental 3. Figure 4-13 shows RGB peaks for alginate + HNTs + BMP62 hydrogel
experimental (E4) for day 0.
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Figure 4-13. Image analysis for Alcian Blue staining Experimental 4 Day 0.
Figure 4-13 shows RGB peaks for Alcian Blue staining for experimental 4 on day
0. Red has more intense staining in the region of interest suggesting high cell
proliferation and blue has very less intensity suggesting little ECM production on day 0.
This observation is supported in the previous section which showed little ECM
production in the experimental 4 on day 0. Figure 4-14 shows RGB peaks for alginate +
HNTs + BMP62 hydrogel experimental (E4) for Day 21.
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Figure 4-14. Image analysis for Alcian Blue staining Experimental 4 Day 21.
Figure 4-14 shows RGB peaks for Alcian Blue staining for experimental 4 on
Day 21. The red has intense staining but it has reduced since day 0 and the intensity for
blue has increased suggesting retardation in the cell proliferation and increase in ECM
production supported by the observations in the previous section suggesting an increase
in the ECM production since day 0 in experimental 4.
These representative image analysis results support the earlier observations made
suggesting that the addition o f HNTs and BMPs 2,4, and 6 improved ECM production
and emhanced cellular differentiation in these constructs when compared to the controls 1
and 2 form days 0 to 21.
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4.3.1.2

Picrosirius Red staining. The Picrosirius Red staining helps to visualize the

collagen secreted by the differentiating cells as a result o f laying foundation of the new
tissue. Collagen is the most abundant substance in connective tissues. [45] It gives the
tissues their elasticity and maintains their structural integrity. [45] Figures 4-5 to 4-8
show the Picrosirius Red staining of the alginate hydrogels enhanced with BMP 2,4,
and 6 loaded HNTs with osteoblasts encapsulated in them for days 0, 7,14, and 21. The
figures are representative and show the days that highlight the trend o f progression of
differentiation and production of collagen as a part of new tissue formation. Figure 4-15
(A-F) shows the Picrosirius Red staining for day 0.

Figure 4-15. Picrosirius Red staining Day 0 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
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In Figure 4-15, Controls 1 and 2 (A and B) show dark spots of cells. Control 2 (B)
shows deeper staining as compared to control 1 (A). Experimental groups 1, 2, 3, and 4
(C-F) show dark patches of cells surrounded by red stained gel matrix containing
collagen. Experimental 2 (D), shows larger cell patches suggesting that more cells
proliferated compared to the other experimental groups, (C, E, and F). The experimental
groups 1 and 2 show deep red staining suggesting that the collagen secretion was more
compared to the experimental groups 3 and 4 (E and F). Figure 4-16 (A-F) shows
Picrosirius Red staining for Day 7.

B)

Figure 4-16. Picrosirius Red staining Day 7 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascoibate E) Experimental 3 Alginate+ HNTs+
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
In Figure 4-16, Controls 1 and 2 (A and B) show dark spots of proliferated cells
and collagen which is stained in red. The amount o f collagen that is produced by the cells
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is more compared to Day 0. Experimental groups #1,2, 3, and 4 (C-F) show more
proliferation of the cells as dark patches are more numerous compared to Day 0.
Experimental groups #2, 3, and 4 (D, E, and F) show deeper staining with Picrosirius Red
suggesting more collagen production as the days advance. The staining of the
experimental groups #2, #3, and #4 (D, E, and F) is darker than the controls indicating
that the hydrogels with BMP 2 and ascorbate, BMP 4 and BMP 6 were performing better
with respect to collagen secretion against the controls. Figure 4-17 (A-F) shows
Picrosirius Red staining for Day 14.
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Figure 4-17. Picrosirius Red staining Day 14 A) Control 1 Alginate-only B) Control 2
Alginate+ HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
In Figure 4-17, controls 1 and 2 (A and B) show deep red staining compared to
days 0 and 7. The experimental groups #1, #2, #3, and #4 (C-F) show deeper staining
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with experimental groups #3 and #4 (E and F) showing a uniform and dark staining. This
suggests that as the days progressed, collagen production increased with collagen
secretion being more uniformly distributed in experimental groups #3 and #4 (E and F).
Experimental groups #1 and #2 (C and D) show more dark patches of cell compared to
group #3 and #4 (E and F). Based on the deep stained gel matrix in experimental groups
#3 and# 4, it can be inferred that the cell patches were not visible because of larger
amounts of collagen being produced by the differentiating cells. Figure 4-18 shows
Picrosirius Red staining for Day 21.

Figure 4-18. Picrosirius Red staining Day 21 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
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In Figure 4-18, controls 1 and 2 (A and B) show lighter staining compared to
experimental groups #l-#4 (C-F). A comparison of all the groups reveals that the
collagen production is at its peak on Day 7. The experimental group #4 (F) shows the
most collagen amongst all the groups (A-E) on Day 21. All the experimental groups show
large cell patches surrounded by collagen they produced.
Comparison o f the experimental groups #l-#4 (C-F) with controls 1 and 2 (A and
B) throughout all days, suggests that there was a marked difference in the cellular
response with respect to collagen production by the experimental groups. The cellular
proliferation and differentiation was more compared to the experimental groups on all
days except Day 7. The difference in the collagen production by the experimental groups
throughout the 21-day period might be the influence of the growth factors (BMP 2,4, and
6) loaded in HNTs. There was also an early onset o f collagen production on Day 0 (8
hours after cellular encapsulation in the hydrogels) in the experimental groups suggesting
collagen production starts early in the hydrogels with growth factor loaded HNTs against
the controls. This may be important as it would trigger faster bone regeneration by
enhanced and early cell differentiation response.
The observations made by visual qualitative analysis of the Picrosirius Red
stained sections o f hydrogels can be further ascertained by image analysis done by Image
J software. The representative images of Controls 1 & 2 and the experimental groups E l,
E 3, and E4 for days 0 and 21 are given in Figure 4-19 to 4-28. Figure 4-19 shows RGB
peaks for alginate-only hydrogel control (C l) for day 0.
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Figure 4-19. Image analysis for Picrosirius Red staining for Control 1 Day 0.
Figure 4-19 shows RGB peaks for Picrosirius Red staining for control 1 on day 0.
The intensity for red color is less as can be seen in the graph for red color. The colors
green and blue show intensities of similar values suggesting that not much red stain
present in the region o f interest which means that the collagen production is very less.
This is expected on day 0 o f the staining and is also supported in the observations made
in the earlier sections. Figure 4-20 shows RGB peaks for alginate-only hydrogel control
(C l) for Day 21.
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Figure 4-20. Image analysis for Picrosirius Red staining for Control 1 Day 21.
Figure 4-20 shows RGB peaks for Picrosirius Red staining for control 1 on Day
21. The red color has a very low intensity and the colors blue and green are more intense.
This suggests that the cellular proliferation is more and collagen production is very less in
control 1 on Day 21. This observation is supported by the observations in the previous
section suggesting that the collagen production remains low in control 1 on Day 21.
Figure 4-21 shows RGB peaks for alginate + HNTs hydrogel control (C2) for day 0.
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Figure 4-21. Image analysis for Picrosirius Red staining for Control 2 Day 0.
Figure 4-21 shows Picrosirius Red staining for control 2 on day 0. All the three
colors show intense staining in the section and this might be due to the section being
thick and appearing darker. The high intensity o f red in this section does not suggest high
collagen production. This inference can be drawn by taking into consideration other
constructs and the behavior of control 2 over advancing days. Figure 4-22 shows RGB
peaks for alginate + HNTs hydrogel control (C2) for Day 21.
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Figure 4-22. Image analysis for Picrosirius Red staining for Control 2 Day 21.
Figure 4-22 shows RGB peaks for Picrosirius Red staining for control 2 on Day
21. The red color shows less intense staining and this suggests less collagen production
over a period of 21 days. This observation can also be supported by looking at the
previous section images for control 2 for 21 day period. Figure 4-23 shows RGB peaks
for alginate + HNTs + BMP 2 experimental (E l) for day 0.
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Figure 4-23. Image analysis for Picrosirius Red staining for Experimental 1 Day 0.
Figure 4-23 shows RGB peaks for Picrosirius Red staining for experimental 1 on
day 0. The peak for red shows a lot of noise and this might be due to the section being
uneven. The intensity for red is still higher than the controls 1 and 2 on day 0. This
suggests that the collagen production has already started in the experimental 1 on day 0.
This observation supports the inference from the previous section that there is early onset
of cellular differentiation in the experimental set 1. Figure 4-24 shows RGB peaks for
alginate + HNTs + BMP 2 experimental (El) for Day 21.
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Figure 4-24. Image analysis for Picrosirius Red staining for Experimental 1 Day 21.
Figure 4-24 shows RGB peaks for Picrosirius Red staining for experimental 1 on
Day 21. The region o f interest here is a dense patch which might be cellular mass
secreting collagen. The high red intensity might indicate high collagen secretion. The
intensities are also high for green and blue colors and that might be due to the thick mass.
The observations are in congruence with the observations from the previous section
suggesting high collagen production in experimental 1 for a 21 day period. Figure 4-25
shows RGB peaks for alginate + HNTs + BMP 4 experimental (E3) for day 0.
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Figure 4-25. Image analysis for Picrosirius Red staining for Experimental 2 Day 0.
Figure 4-25 shows RGB peaks for Picrosirius Red staining for experimental 2 on
day 0. There is a high intensity blue color and also a pronounced green color for the
region o f interest. The red color has the least intensity suggesting that the collagen
secretion is low on day 0. The different intensity values for green and blue colors might
be due to the uneven sectioning. Figure 4-26 shows RGB peaks for alginate + HNTs +
BMP 4 experimental (E3) for Day 21.
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Figure 4-26. Image analysis for Picrosirius Red staining for Experimental 3 Day 21.
Figure 4-26 shows RGB peaks for Picrosirius Red staining for experimental 3 on
Day 21. The intensity for green is high and red also has relatively higher intensity
suggesting an increased collage production over 21 day period. This observation is
supported by the observations in the previous section that the collagen production in
experimental 3 increased from day 0 to Day 21. Figure 4-27 shows RGB peaks for
alginate + HNTs + BMP 6 experimental (E4) for day 0.
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Figure 4-27. Image analysis for Picrosirius Red staining for Experimental 4 Day 0.
Figure 4-27 shows RGB peaks for Picrosirius Red staining for experimental 4 on
day 0. The region of interest shows a red colored dense patch however, the red color has
low intensity as can be seen in the graph for red. The intensities are high for green and
blue suggesting the density of the region being high. This might be due to sectioning or
due to collagen deposition. A high intensity green staining for Picrosirius Red is also an
indicator for deposition o f collagen type III. But it needs further investigation to find out
which type o f collagen is being deposited in the hydrogel matrix. Figure 4-28 shows
RGB peaks for alginate + HNTs + BMP 6 experimental (E4) for Day 21.
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Figure 4-28. Image analysis for Picrosirius Red staining for Experimental 4 Day 21.
Figure 4-28 shows RGB peaks for Picrosirius Red staining for experimental 4 on
Day 21. The region of interest shows intensity for red is scattered and it might be due to
an uneven section or presence of dense bodies of cellular material. The intensities for
green and blue are also high and this might be indication of presence of dense material in
die selected area. This observation is supported by the observations in the previous
section suggesting high amount of collagen being secreted in the cellular clusters forming
dense bodies.
The observations from the image analysis for Picrosirius red stain suggest that the
experimentals 1,3, and 4 performed better with respect to collagen secretion and also
there was an increase in the collagen secretion as the days advanced from 0 to 21. It can
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be inferred that the addition o f HNTs loaded with growth factors like BMP 2,4, and 6
enhanced cellular differentiation in the hydrogel constructs.
4.3.1.3

Von Kossa stainim. The Von Kossa stain is 5% v/v silver nitrate which

reacts with the phosphate group of calcium phosphate which is the mineral component
o f bone. Calcium phosphate is secreted by the cells during differentiation. Figures 4-29
to 4-32 (A-F) show Von Kossa staining of the alginate hydrogels for days 0 to 21.
Figure 4-29 (A-F) shows the Von Kossa staining for Day 0.

Figure 4-29. Von Kossa staining Day 0 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Aiginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
Day 0 shows the staining done after 8 hours of encapsulating the cells in
hydrogels. Figure 4-29 (A-F) shows that the cells have not started their differentiation in
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any o f the control or experimental groups. This is because the initial stage for the cells is
to establish anchorage in the matrix and then to produce ECM for cellular communication
for differentiation.

Figure 4-30. Von Kossa staining Day 7 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
In Figure 4-30, the controls 1 and 2 (A and B) show small areas of black-brown
coloration which are calcium phosphate deposits stained with Von Kossa. The
experimental groups (C-F) show larger brown-black patches of calcium phosphate
deposits stained with Von Kossa. Once the osteoblasts have proliferated and established
connections with each other they start differentiating and produce substances which lay
foundation of new bone such as calcium phosphate. Usually this process starts by Day 7.
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The images of the experimental groups (C-F) show the progression of deposition of
calcium phosphate by the differentiating cells. Amongst the experimental groups the
groups #1 and #3 (C and E) show distinct black depositions of calcium phosphate shown
by arrows.

Figure 4-31. Von Kossa staining Day 14 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
Figure 4-31 (A-F) shows the progression of calcium phosphate deposition by the
differentiating osteoblasts on Day 14. The cells have formed distinct deposits of calcium
phosphate seen in all the groups (controls and experimental) as brown-black patches.
From the images it can be inferred that the deposition of calcium phosphate in the
hydrogel matrix is more pronounced on Day 14 than the onset of differentiation (Day 7).
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The experimental groups #3 and #4 (C and D) have more depositions than the controls or
experimental groups #1 and #2 (seen as deeply stained hydrogel matrix without distinct
patches).

Figure 4-32. Von Kossa staining Day 21 A) Control 1 Alginate-only B) Control 2
Alginate + HNTs C) Experimental 1 Alginate+ HNTs+ BMP 2 D) Experimental 2
Alginate+ HNTs+ BMP 2 with 0.4M Ascorbate E) Experimental 3 Alginate+ HNTs+
BMP 4 F) Experimental 4 Alginate+ HNTs+ BMP 6.
Figure 4-32 (A-F) shows the progression of calcium phosphate deposition on Day
21. Compared to the controls 1 and 2 (A and B) the experimental groups (C-F) have more
calcium phosphate deposition. Amongst all the experimental groups, experimental groups
#3 and #4 (E and F) have the most pronounced deposition seen as deeply stained
hydrogel matrix.
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Comparing the images of Von Kossa staining, the controls and the experimental
groups through the 21-day period show that the deposition of calcium phosphate starts on
Day 7 and is more in the experimental groups #3 and #4 (E and F). This suggests that the
hydrogels having BMP 4 and 6 loaded HNTs perform better with respect to other groups.
The observations made by visual qualitative analysis of the Von Kossa stained
sections of hydrogels can be further ascertained by image analysis done by Image J
software. The representative images of Controls 1 & 2 and the experimental groups E l, E
3, and E4 for days 0 and 21 are given in Figure 4-33 to 4-42. Figure 4-33 shows
Grayscale intensity for alginate-only hydrogel control (C l) for day 0.
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Figure 4-33. Grayscale intensity for Von Kossa staining for Alginate-only hydrogel
control 1 (C l) for Day 0.
Figure 4-33 shows grayscale intensity for Von Kossa staining for control 1 on day
0. The grayscale intensity value will show how dark was the staining in the region of
interest suggesting increased or slight mineral deposition of hydroxyapatite crystals. The
grayscale graph shows less intense staining suggesting that the mineral deposition was
not much on day 0 for control 1. Figure 4-34 shows Grayscale peak for alginate-only
hydrogel control (C l) for Day 21.
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Figure 4-34. Grayscale intensity for Von Kossa staining for Alginate-only hydrogel
control 1 (C l) for Day 21.
Figure 4-34 shows grayscale intensity for Von Kossa staining for control 1 on
Day 21. The grayscale graph does not show much change in the intensity for the stain
suggesting that there was not much mineralization in the control 1 hydrogel matrix after
21 day period. Figure 4-35 shows Grayscale peak for alginate + HNTs hydrogel control
(C2) for day 0.
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Figure 4-35. Grayscale intensity for Von Kossa staining for Alginate + HNTs hydrogel
control 2 (C2) for Day 0.
Figure 4-35 shows grayscale intensity for Von Kossa staining for control 2 on day
0. The intensity o f the stain is less on day 0 for control 2 suggesting that the
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mineralization has not yet started. Figure 4-36 shows Grayscale peak for alginate + HNTs
hydrogel control (C2) for Day 21.
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Figure 4-36. Grayscale intensity for Von Kossa staining for Alginate + HNTs hydrogel
control 2 (C2) for Day 21.
Figure 4-36 shows grayscale intensity for Von Kossa staining for control 2 on
Day 21. The intensity for the staining has increased from day 0 suggesting mineralization
and calcium phosphate deposition. This observation is supported by the obsevations in
the previous section. Figure 4-37 shows Grayscale peak for alginate + HNTs + BMP 2
experimental (E l) for day 0.
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Figure 4-37. Grayscale intensity for Von Kossa staining for Alginate + HNTs + BMP 2
experimental 1 (El) for Day 0.
Figure 4-37 shows grayscale intensity for Von Kossa staining for experimental 1
on day 0. The intensity for the stain can be compared to the day 0 values of controls 1 and
2. The intensity is low for the staining suggesting that the mineralization has not yet
started on day 0. Figure 4-38 shows Grayscale peak for alginate + HNTs + BMP 2
experimental (E l) for Day 21.
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Figure 4-38. Grayscale intensity for Von Kossa staining for Alginate + HNTs + BMP 2
experimental 1 (E1) for Day 21.
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Figure 4-38 shows the grayscale intensity for Von Kossa staining for
experimental 1 on Day 21. The grayscale intensity for the region o f interest shows an
increase suggesting that there is mineralization and it is more than that of the controls 1
and 2 on Day 21. Figure 4-39 shows Grayscale peak for alginate + HNTs + BMP 4
experimental (E3) for day 0.
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Figure 4-39. Grayscale intensity for Von Kossa staining for Alginate + HNTs + BMP 4
experimental 3 (E3) for Day 0.
Figure 4-39 shows grayscale intensity for Von Kossa for experimental 3 on day 0.
The graph for the grayscale shows low intensity o f staining suggesting that the
mineralization has yet to start. Figure 4-40 shows Grayscale peak for alginate + HNTs +
BMP 4 experimental (E3) for Day 21.
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Figure 4-40. Grayscale intensity for Von Kossa staining for Alginate + HNTs + BMP 4
experimental 3 (E3) for Day 21.
Figure 4-40 shows grayscale intensity for Von Kossa for experimental 3 on Day
21. The graph for the grayscale shows a very high intensity value for the region of
interest. It suggests that the region o f interest has calcium phosphate deposits indicating
mineralization. The increase in the mineralization from day 0 to 21 and also a comparable
increase in the mineral deposition against controls 1 and 2 is supported by the
observations in the previous section. Figure 4-41 shows Grayscale peak for alginate +
HNTs + BMP 6 experimental (E4) for day 0.
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Figure 4-41. Grayscale intensity for Von Kossa staining for Alginate + HNTs + BMP 6
experimental 4 (E4) for Day 0.

Figure 4-41 shows grayscale intensity for Von Kossa for experimental 4 on day 0.
There is noise in the grayscale graph which might be due to uneven sectioning but the
overall value is comparable to the controls 1 and 2 on day 0. This suggests that the
mineralization has not yet started for experimental 4 on day 0. Figure 4-42 shows
Grayscale peak for alginate + HNTs + BMP 6 experimental (E4) for Day 21.
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Figure 4-42. Grayscale intensity for Von Kossa staining for Alginate + HNTs + BMP 6
experimental 4 (E4) for Day 21.
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Figure 4-41 shows grayscale intensity for Von Kossa for experimental 4 on Day
21. There is noise in the graph which might be due to uneven sectioning or high mineral
deposits but the overall intensity for the staining has increased. This indicates high
mineral deposition in the experimental 4 matrix on Day 21. It can be inferred taking into
consideration the image analysis for Von Kossa that the experimental 1,3, and 4
performed better with respect to the mineralization. The addition of HNTs and BMPs 2,
4, and 6 enhanced die mineralization promoted cellular differentiation in the respective
hydrogel constructs.
Comparing all the three histochemical staining images (Alcian Blue, Picrosirius
Red, and Von Kossa, Figures 4-29 to 4-32) a progression of events can be visualized. The
ECM production starts early (Day 7) in experimental groups #3 and #4 (hydrogels with
BMP 4 and 6 loaded HNTs). The experimental groups #3 and #4 also show early onset of
collagen production (Day 0 ,8 hours after cell encapsulation). In the case o f Von Kossa
staining, the experimental groups #3 and #4 have the most calcium phosphate deposition
on Day 7 amongst all the four experimental groups.
The observations from all the three histochemical staining analyses suggest that
experimental groups #3 and #4 performed better with respect to early onset of
differentiation of osteoblasts. The experimental groups #1 and #2 performed better
compared to the controls 1 and 2 with respect to differentiation o f osteoblasts (production
of ECM, collagen and calcium deposition). The results from the histochemical analyses
suggest that the hydrogel enhanced with growth factors loaded Halloysite perform better
than the control hydrogels o f calcium alginate and calcium alginate+ HNTs. This is also
substantiated by the image analysis of the histochemical staining images by Image J
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software which showed that there was indeed an increase in ECM and collagen
production and mineral deposition in experimental sets 1, 3, and 4.
4.3.2

Release Profile Study of BMP 2 from HNTs
The release profile study of BMP 2 from HNTs was measured with custom made

sandwich ELISA kits, to estimate the amount of BMP 2 eluted out of the HNTs over a
period of 24 hours and 7 days. This measurement was done to investigate if the amount
o f growth factor eluted from the HNTs was similar to the amount secreted in the body
and to mimic the natural internal environment. Figure 4-43 is the calibration curve for the
ELISA kit with known standards.
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Figure 4-43. Calibration curve for BMP 2 standards.
Absorbance is on the Y-axis and concentrations of the standard is on X-axis.
Figure 4-44 shows the conversion plot for absorbance to log concentrations used to
calculate BMP 2 release, y = O.OOOSx + 0.0561.

86

Optical Density
2.5
2

y = 1.265!
„

uc

1.5

Linear (OD)

0
-0.5

0

1

2

3

4

Log Concentration

Figure 4-44. Graph showing conversion of absorbance to log concentrations.
Figure 4-45 shows the trend of BMP 2 release from HNTs for a period o f 24
hours. The release was achieved by the vacuum loaded HNTs in HBSS at room
temperature. The amount o f BMP 2 release was estimated by sandwich ELISA and
reading the plate on absorbance plate reader. The experiment was repeated thrice to
reduce error and to check for the reproducibility of results. The values are the means of
the readings o f BMP 2 from HNTs at the respective time points recorded from the three
repetitions of the experiment. The error bars reflect the standard deviation at each data
point calculated by standard deviation and the average of the triplicate samples (detailed
process of calculation o f the standard deviation described in Appendix B). [59]
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Figure 4-45. Release profile o f BMP 2 from HNTs for 24 hours.
The graph shows a sustained release o f the growth factor for 24 hours in the range
o f picograms per ml which is comparable to the range the growth factors are secreted in
the body. [54] HNTs are cylindrical in shape with the inner lumen comprising of
concentric layers o f aluminosilicate. When any drug or bioactive agent is vacuum-loaded
into the HNTs, the molecules become trapped in both the lumen and the outer surface.
Before starting the release study of BMP 2 we washed the sample o f loaded HNTs with
distilled water twice to remove the BMP 2 coated on the outer surfaces o f the HNTs. It
cannot be guaranteed that all the molecules are removed during the washing step as can
be seen in the initial burst release o f BMP 2 within first one hour of the study. The trend
seen here is not of the cumulative release but that o f individual data points. The
concentration seen in the graph cannot be regarded as accurate estimate as the standards
provided by the manufacturer showed resolution problems. The data should be viewed
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cautiously and regarded as a qualitative estimate of the protein released from the HNTs.
The raw data tables and supplementary tables are provided in Appendix B.
The graph of the release profile study for BMP 2 from HNTs for 7 days is given
in the Figure 4-46. The calibration curves in Figures 4-43 and 44 were used to the
calculations in the plotting of graph in Figure 4-46.
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Figure 4-46. The graph of the release profile study for BMP 2 from HNTs for 7 days.
The release profile study of BMP 2 from HNTs was extended for a period of 7
days. The experiment was repeated three times to reduce error and check for
reproducibility o f the results. The values are the means of the readings of BMP 2 from
HNTs at the respective time points recorded from the three repetitions of the experiment.
The error bars reflect the standard deviation at each data point calculated by standard
deviation and the average o f the triplicate samples (detailed process of calculation o f the
standard deviation described in Appendix B). [59]
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The release o f BMP 2 from HNTs was extended and sustained for a period of 7
days. The initial release was in picograms per ml range and after 24 hours was in
nanograms per ml range. This range of released BMP 2 is comparable to the range BMP
2 is effective in the body. The graph for BMP 2 release from the HNTs for a period of 7
days shows a release profile which is characterized by an initial high burst o f BMP 2
release within initial 24 hours and later steady release for the period of 7 days. As
described earlier, the release profile of BMP 2 for 24 hours was estimated by the use of
custom made sandwich ELISA kits. The trend seen here is not of the cumulative release
but that o f individual data points. The concentration seen in the graph cannot be regarded
as accurate estimate as the standards provided by the manufacturer showed resolution
problems. The data should be viewed cautiously and regarded as a qualitative estimate of
the protei released from the HNTs. The raw data tables and supplementary tables are
provided in Appendix B.
The release profile of BMP 2 from the HNTs suggests that an extended and
sustained release can be obtained from HNTs for a period of 7 days. The release is in pico
and nanograms range which is the effective range for BMP 2 in natural tissue
environment. Even though the concentrations cannot be regarded as accurate due to the
resolution error in the kit, especially below the concentration o f 50 pg/ml, the qualitative
trend shows that the range in which the BMP 2 is released is comparable to the effective
range in natural tissues. The results obtained for 7-day release are encouraging as the
cellular differentiation process peaks at Day 7. Hence, a sustained release of BMP 2 for a
period of 7 days from HNTs is beneficial for early onset of cellular differentiation which
might lead to accelerated regeneration of the damaged bone tissue.
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The study o f release o f BMP 2 from HNTs could not be extended beyond 7-day
period as the growth factor degrades structurally at room temperature if kept beyond a
week. A comparison o f release profiles of BMPs 4 and 6 from HNTs with BMP 2 would
have been ideal but could not be conducted as no ELISA kits were commercially
available to detect these molecules at picogram or nanogram range.
4.3.3

4.3.3.1

FE-SEM imagine and material testing with BET pore size
and surface area analyses
FE-SEM imaging. Lyophilized calcium alginate hydrogel beads with and

without HNTs were FE-SEM imaged to visualize and compare the surface
morphologies of the beads. The study of the surface morphology is important as it
reveals changes that addition o f HNTs brings about in calcium alginate hydrogels. A
modified surface might be more desirable with respect to the biological properties of
the hydrogel and might suggest other differences in the mechanical properties o f the
HNT-calcium alginate hydrogels. Figure 4-47 compares the general morphologies of
lyophilized alginate-only and alginate+ HNTs hydrogel beads at 500 pm and 1 mm
magnification, respectively.

Figure 4-47. FE-SEM images showing A) Alginate-only bead and B) Alginate+ HNTs
bead.
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Figure 4-47 (A) shows the general morphology of lyophilized alginate-only beads
at 500 pm. The surface of the bead appears to have ridges and folds. Figure 4-47 (B)
shows the general morphology of lyophilized alginate+ HNTs beads at 1 mm. The
surface of the bead appears to have less ridges and folds than alginate-only bead (A). The
surface also appears rougher than the alginate-only bead (A). The beads were imaged at
different magnifications (500 pm for alginate-only bead and 1 mm for alginate+ HNT
bead) as the alginate-only bead shrunk in size and surface features were not clearly
visible at 1 mm magnification. Figure 4-48 (A-D) shows surface morphologies of
alginate-only and alginate+ HNTs hydrogel beads at higher magnification.
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Figure 4-48. FE-SEM images showing the surface morphology of A) Alginate-only bead
100 pm magnification B) Alginate+ HNTs bead 100 pm magnification C) Alginate-only
bead 1 pm magnification D) Alginate+ HNTs bead with HNT protruding out of the
surface at 1 pm magnification.
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Figures 4-48 (A and B) show the surfaces of alginate-only bead and alginate+
HNTs bead, respectively, at 100 pm magnification. The surfaces of both the beads look
different with the image B showing a relatively rougher surface of alginate+ HNTs
hydrogel bead. At 1 pm magnification the surface of alginate-only bead (C) looks rough
and has finer creases and cracks. The image D shows the surface o f alginate+ HNTs
hydrogel bead with halloysite sticking out of the bead’s surface. The surface of the bead
in image D also shows fold and minute surface elevations which might be due to
halloysite bunches trapped in the hydrogel matrix.
A comparison of images in Figures 4-47 (A and B) and 4-48 (A-D) shows that the
addition of HNTs modifies the surface of the hydrogels by making it rough and the bead
more rigid. The rigidity o f the bead with HNTs was more as it did not shrink after
lyophilization and retained it surface integrity without cracking.
4.3.3.2

BET pore size and surface area analysis o f hydrogels. BET pore size and

surface area analysis was done with helium adsorption-desorption method to analyze
the material properties o f the alginate-only and alginate+ HNTs hydrogels. This
analysis would help to assess the differences in the material properties o f the hydrogels
with the addition of HNTs. The curve used to plot the adsorption-desorption curve of
helium for both the types o f hydrogels is Langmuir curve. Figure 4-49 shows BET
Langmuir isotherm showing the adsorption-desorption of helium for alginate-only
hydrogel.
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Figure 4-49. BET Langmuir isotherm showing the adsorption-desorption o f helium for
alginate-only hydrogel.
Figure 4-49 shows Langmuir isotherm of adsorption-desorption o f helium for
alginate-only hydrogel. The red isotherm line is for adsorption of helium and blue line is
for desorption. Both the lines (adsorption and desorption) have values that coincide for
volume o f gas at the respective values of relative pressure. The summary o f analysis
showed that the cumulative surface area for the alginate-only hydrogel was 2.264 m2 /g,
cumulative pore volume was 3.054 cc /g, and pore radius was 1.385 A. Figure 4-50
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shows BET Langmuir isotherm showing the adsorption-desorption of helium for
alginate+ HNTs hydrogel.
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Figure 4-50. BET Langmuir isotherm showing the adsorption-desorption of helium for
alginate+ HNTs hydrogel.
Figure 4-50 shows BET Langmuir isotherm o f adsorption-desorption of helium
for alginate+ HNTs hydrogel. The red isotherm line is for adsorption of helium, and the
blue line is for desorption. Both the lines, unlike the isotherm curve for alginate-only
hydrogel, show that the values for volumes of adsorbed and desorbed helium differ at the
respective values o f relative pressure. The results are summarized in Table 2.
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Table 2: BET results summary
Alginate

Alginate + HNTs

Surface Area

8.485 m2/g

6.955 m2/g

Pore Volume
(Cumulative)

3.054 cc /g

2.325 cc /g

1.385 A

l.o io A

Hydrogels

Pore Radius

A comparison o f both the isotherms in Figures 4-49 and 4-50 shows that
adsorption and desorption profiles of helium are different for both the types of hydrogels.
The summary of analysis shows that the hydrogels also differ in their cumulative pore
sizes and pore volumes significantly as can be seen in Table 2. Cumulative surface area
of the hydrogels also differs slightly for both the types o f hydrogels. The alginate-only
hydrogels have slightly larger cumulative surface area (2.264 m2 /g) than the alginate+
HNT hydrogels (2.099 m2 /g). The alginate-only hydrogels have cumulative pore volume
of 3.054 cc /g which is larger than the cumulative pore volume of alginate+ HNTs
hydrogels (cumulative pore volume = 2.325 cc /g). The pore size of alginate-only
hydrogels is larger (pore radius = 1.385

A) than alginate+ HNT hydrogels (pore radius =

1.01 A).
The summary o f the BET pore size and surface area analysis suggests that
addition of HNTs make the alginate hydrogels more rigid by reducing the pore size and
volume. This alteration o f material properties by the addition o f HNTs might make the
Halloysite enhanced hydrogels better candidates than alginate-only hydrogels for implant
materials.
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Looking at the results from the FE-SEM surface morphology analysis (Figure 447 and 4-48) and BET pore size and surface area analysis (Table 2, Figure 4-49 and 4-50)
suggests that alginate+ HNTs have more rough surface and rigid structure making them
structurally better suited as implant materials.

CHAPTER 5
NANOSEEDS
5.1

Introduction

In the previous chapter, the concept of nanoenhanced bioactive hydrogels was
discussed in detail. The results suggest that hydrogels can be enhanced with HNTs to
improve their material and biological properties. Another potential application is the use
o f nanoenhanced hydrogels as a chemoattractive delivery system designed to recruit the
body’s own cells to populate and regenerate damaged bone tissue.
In Chapter 4, the base material for the hydrogels was calcium alginate. In the
current chapter, calcium alginate is combined with similar materials such as calcium
phosphate cement (CPC), chitosan lactate, and HNTs. The hydrogel composites
comprised o f calcium alginate, CPC, and chitosan were enhanced with HNTs loaded with
BMP 2. The objective o f the addition of the mentioned materials was to develop scaffold
materials that can be used as chemoattractant beacons to attract progenitor cells to the site
of injury.
CPCs, individually and in combination with chitosan lactate, has material
properties which make them suitable materials to be used as bone cement. [25] Unlike
PMMA, they do not produce toxic monomers or require high setting temperatures. [25,
27] Apart from their desired material properties they also provoke a histogenic response
from osteoblasts and mesenchymal stem cells. [25]
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The hypothesis of this project was that the combination of calcium alginate, CPC,
and chitosan with BMP 2-loaded HNTs would enhance the material properties of the
scaffolds and would act as chemoattractants for the osteoprogenitor cells.

5.2

Materials and Methods

All plasticware was obtained from Mid Scientific, St. Louis, MO. The chemicals
met the ACS standards and purchased from Sigma Aldrich. Preosteoblasts were obtained
from ATCC, Manassas, VA. The cell culture growth and maintenance medium were
obtained from GEBCO, Life Technologies. The growth factor, BMP 2, was purchased
from ProSpec Militany, Tel Aviv, Israel. The collagen type I, used for coating the seeding
12 well plates, was obtained from GIBCO, Life Technologies (Grand Island, NY). The
NucBlue Live Ready Probes, fluorescent vital stain was obtained from Thermo Fisher
Scientific (Grand Island, NY). Histochemical stain kits: Von Kossa, Alcian Blue, and
Picrosirius Red, were purchased from Polysciences Inc. (Warrington, PA).
5.2.1

Cell Migration Study
The cell migration study needed a matrix to hold the nanoseed constructs in place.

The matrix also created a space where the cells could be seeded and held until they
attached and began active migration. The matrix was made o f collagen type I as it would
mimic the body’s internal conditions and is an often used material in bioengineering.
Collagen type I is the most abundant component o f connective tissues in the body, in the
scar tissue and also makes up the organic component o f bones. [45]
5.2.1.1

Coatine cell culture well plates and seedine. The coating procedure is

described in Section 3.2.4. After coating the wells, the plates were kept in 37 °C
incubator for the collagen gels to form. The gels were lightly washed with HBSS buffer
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to remove the traces o f chemicals. Hydrogel nanoseed constructs were prepared as per
the procedure described in Section 3.2.1 and enhanced with HNTs vacuum loaded with
BMP 2 as per the process described in Section 3.2.2.1. The nanoseeds were placed at a
comer o f the coated well and cell suspension was injected in the collagen matrix at the
opposite comer. The growth medium was added after 30 minutes to avoid eluting out
the seeded cells. The cells in the suspension were treated with NucBlue fluorescent
stain as per the procedure described in Section 3.2.5.2.
5.2.1.2

Fixing the eel matrices and histochemical stainine. The gel matrices with the

nanoseeds and the cells were fixed on Days 0, 3, and 7. The cells were imaged on the
respective days to visualize their migration in response to the eluted BMP 2 from the
nanoseeds. The differentiation response of the cells was visualized by staining with
histochemical stains (Alcian Blue and Von Kossa). The histochemical staining
procedures for Alcian Blue and Von Kossa are described in details in Sections 3.2.5.3,
3.2.5.4, and 3.2.5.5 Picrosirius Red staining was not suitable for this study as the cells
were seeded on collagen gel matrix and Picrosirius Red stains for collagen.
5.2.2

Release profile study o f BMP 2 from HNTs and various
hvdrogel composites
The release profile for BMP 2 was studied in the previous project with the

alginate hydrogels. This release profile study focused only on the elution of BMP 2 from
the HNTs. For the nanoseed hydrogels to be chemoattractant, the BMP 2 needs to be
eluted out o f the hydrogels. In this project, the release profile of BMP 2, both from HNTs
and hydrogels enhanced with HNTs loaded with BMP 2, was studied. The detailed
procedure for release profile study is given in Section 3.2.6.
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5.2.3

FE-SEM imagine and comparison of surface morphologies of
different hvdroeel composites
The hydrogel composites consisting of calcium alginate as the base material were

enhanced with materials like CPC, chitosan lactate, and HNTs. This was done to improve
the mechanical properties and also the osteogenic response of the bone progenitor cells.
[25]
To compare and contrast the different surface morphologies of the hydrogel
composites, the hydrogel constructs were lyophilized and imaged under FE-SEM. The
detailed process is described in Section 3.2.3.
5.2.4

Preosteoblast pilot study using the composite hydrogels
The cells after migration should be able to proliferate and differentiate on the

hydrogel composites to achieve the purpose o f tissue regeneration. A pilot study was
conducted to test if the hydrogels provide the cells a favorable surface for differentiation.
The cells were seeded onto the hydrogel composite films directly. The study was
conducted for a period o f 3, 7, and 14 days. The hydrogel composite films were fixed
with the cells on them on Day 3, 7, and 14. As the films were too thick for the light to
pass through, microscopic imaging could not be performed. Instead, the films were
subjected to an indirect stain elution study to quantify the differentiation markers.
The films were stained as per the protocols for Alcian Blue and Picrosirius Red
stains. The stained films were then washed with 7% v/v acetic acid and the stains were
eluted with the samples stored at 4°C. The UV/VIS mode of NANODROP 2000
spectrophotometer was used to determine the absorbance of the samples and the values
were plotted to estimate the amount o f mucopolysaccharides, in case of Alcian Blue
stain, and collagen, in case of Picrosirius Red stain.
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5.3

Results and Discussion

This section discusses the results from experiments detailed in Section 5.2 of the
current chapter.
5.3.1

Histochemical Analysis
The histochemical analysis of the gel matrices seeded with preosteoblasts and

hydrogel composite constructs was done to assess if the cells migrated and differentiated
in response to the secreted BMP 2. If the cells were found to have moved from the
location o f injection or seeding (cell reservoir), it would suggest the chemoattractant
potential o f the HNT-BMP 2 enhanced hydrogel composites.
5.3.1.1

Alcian Blue staininz. Alcian Blue staining, in this project, was done to

analyze the response o f the cells to the secreted BMP 2 during or after their migration
towards the hydrogels or nanoseeds. Alcian Blue stains the acidic mucopolysaccharides
of the ECM formed after the cellular differentiation. Figures 5-1 to 5-3 show the Alcian
Blue staining for Days 1, 3, and 7. Figure 5-1 (A-F) shows the Alcian Blue staining for
Day 1.
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Figure 5-1. Day 1 Alcian Blue Staining of the preosteoblast cells on collagen matrices
with hydrogel nanoseed constructs. A) Well 1 with alginate-only hydrogels B) Well 2
with alginate+ HNT+ BMP 2 C) Well 3 alginate+ CPC + HNT D) Well 4 alginate +
CPC+ HNT+ BMP 2 E) Well 5 alginate+ CPC+ Chitosan lactate + HNT F) Well 6
alginate+ CPC+ Chitosan lactate + HNT+ BMP 2.
Figure 5-1 (A-F) shows Day 1 Alcian Blue staining for the cells in response to
different hydrogel composite constructs with or without BMP 2. These images only show
the cell reservoir that is the site o f initial cell seeding. The cells have attached themselves
and are proliferating in the collagen I matrix after seeding. Figure 5-1 (A) shows the
control with alginate-only hydrogel construct and cells seeded in cell reservoir at the
opposite pole. Figures 5-1 (B-F) are all experimental groups showing alginate hydrogel
composite constructs. In all the groups (control and experimental) the cells are attached to
the collagen matrix and are proliferating. This state suggests that the matrices have
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retained their cellular properties and the cells are growing normally in the matrix. Figure
5-2 shows Day 3 Alcian Blue staining.
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Figure 5-2. Day 3 Alcian Blue staining o f the preosteoblast cells on collagen matrices
with hydrogel nanoseed constructs. A) Well 1 with alginate-only hydrogels, site of initial
seeding B) Well 1 with alginate-only hydrogels, center C) Well 2 with alginate+ HNT+
BMP 2, site o f initial seeding D) Well 2 with alginate+ HNT+ BMP 2, center E) Well 3
alginate+ CPC+ HNT, site o f initial seeding F) Well 3 alginate+ CPC+ HNT, center G)
Well 4 alginate + CPC+ HNT+ BMP 2, site of initial seeding H) Well 4 alginate + CPC+
HNT+ BMP 2, center I) Well 5 alginate+ CPC+ Chitosan lactate + HNT, site of initial
seeding J) Well 5 alginate+ CPC+ Chitosan lactate + HNT, center K) Well 6 alginate+
CPC+ Chitosan lactate + HNT+ BMP 2, site of initial seeding L) Well 6 alginate+ CPC+
Chitosan lactate + HNT+ BMP 2, center.
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Figure 5-2 (A-L) shows Day 3 staining of the cells in response to the hydrogel
composites or nanoseeds. Figure 5-1 (A and B) shows cells at the site o f injection and
center, respectively, for alginate-only hydrogels (control). The images show that the cells
have proliferated and have started producing ECM at the site of injection or seeding but
there is no migration towards the hydrogel bead. This suggests that the alginate itself
does not have chemoattractant properties. Figure 5-2 (C and D) shows cells at the site of
injection and center, respectively, for alginate+ HNTs+ BMP 2 (experimental group).
The images show the cells attached and producing ECM. Some of the cells have migrated
towards the bead in response to BMP 2 as seen in the image D.
Figure 5-2 (E and F) shows cells at the site of injection and center, respectively,
for alginate+ CPC+ HNTs. The images show the cells attached and producing ECM.
There is no migration towards the bead suggesting the composite (alginate+ CPC+
HNTs) is not chemoattractant in itself. Figure 5-2 (G and H) shows cells at the site of
injection and center, respectively, for alginate+ CPC+ HNTs+ BMP 2. The images show
the cells have attached and are producing ECM. Some o f the cells have also migrated
towards the hydrogel composite bead in response to BMP 2.
Figure 5-2 (I and J) shows cells at the site of injection and center, respectively, for
alginate+ CPC+ Chitosan lactate+ HNTs. The images show that the cells have attached
and are producing ECM but there is no migration towards the hydrogel composite bead
suggesting that the composite bead is not chemoattractant. Figure 5-2 (K and L) shows
cells at the site o f injection and center, respectively, for alginate+ CPC+ Chitosan
lactate+ HNTs+ BMP 2. The images show that the cells have attached and are producing
ECM. The image showing the center (L) of die gel matrix shows that some o f the cells
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have migrated towards the bead in response to the BMP 2. Figure 5-3 (A-L) shows
Alcian Blue staining for Day 3.
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Figure 5-3. Day 7 Alcian Blue staining of the preosteoblast cells on collagen matrices
with hydrogel nanoseed constructs. A) Well 1 with alginate-only hydrogels, site of initial
seeding B) Well 1 with alginate-only hydrogels, center C) Well 2 with alginate+ HNT+
BMP 2, site of initial seeding D) Well 2 with alginate+ HNT+ BMP 2, center and near
bead (insert) E) Well 3 alginate+ CPC + HNT, site o f initial seeding F) Well 3 alginate+
CPC + HNT, center G) Well 4 alginate+ CPC+ HNT+ BMP 2, site of initial seeding H)
Well 4 alginate + CPC+ HNT+ BMP 2, center and near bead (insert) I) Well 5 alginate+
CPC+ Chitosan lactate + HNT, site of initial seeding J) Well 5 alginate+ CPC+ Chitosan
lactate + HNT, center K) Well 6 alginate+ CPC+ Chitosan lactate+ HNT+ BMP 2, site of
initial seeding L) Well 6 alginate+ CPC+ Chitosan lactate+ HNT+ BMP 2, center and
near bead (insert).
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Figure 5-3 (A-L) shows Day 7 Alcian Blue staining for the cells in response to
different hydrogel composite constructs with or without BMP 2. Figure 5-3 (A and B)
shows cells that have produced deep blue stained ECM at the site of injection (A) and no
migration towards the control bead (B). Figure 5-3 (C and D) shows deeply stained ECM
producing cells at the site o f injection (C), migrating cells at the center and also to the end
where the alginate+ HNTs+ BMP 2 hydrogel bead is located (D, and the insert). The
migrating cells are also more as compared to the Day 3 images (Figure 5-2, D).
Figure 5-3 (E and F) shows cells producing deep blue stained ECM (E) and no
migration towards the alginate+ CPC+ HNTs bead (F). Figure 5-3 (G and H) shows the
cells that are producing deep blue stained ECM (G) and there is migration towards the
alginate+ CPC+ HNTs+ BMP 2 bead shown by the image H and the insert. The cells at
the center o f the collagen gel matrix show that they have started differentiating and some
o f the cells have migrated near the bead.
Figure 5-3 (I and J) shows the cells producing deep blue stained ECM matrix and
no migration towards alginate+ CPC+ Chitosan lactate+ HNTs bead. Figure 5-3 (K and
L) shows a dense ECM matrix produced by the cells and no individual cells can be seen
in the matrix. The site o f injection shows a continuous ECM produced by the
differentiating cells (K) and the cells that have migrated towards the bead have produced
ECM as well as can be seen in image L and insert.
As can be seen in Figure 5-3 (K and L), the migration is complete and the cells
produce ECM in response to the BMP 2. This is the construct that has the most cells
migrating and producing ECM uniformly as compared to other constructs. The images
with constructs or nanoseeds with BMP 2 in the HNTs show that cells are attracted

109
towards them and differentiate. The alginate composites without the growth factor, BMP
2, are not chemoattractants.
5.3.1.2

Von Kossa staining. Von Kossa stains the phosphate group, in calcium

phosphate, brown-black. Calcium phosphate is also known as hydroxyapatite and is the
inorganic component o f bone. The Von Kossa staining, in this project, would help in
visualizing the calcium phosphate secreted by the cells in response to the BMP 2
released from the hydrogel constructs. Figures 5-4, 5-5, and 5-6 show the Von Kossa
staining for alginate hydrogel composites or nanoseeds. Figure 5-4 (A-F) shows the
Von Kossa staining o f the cells for different alginate hydrogel composites or nanoseeds
on Day 1.
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Figure 5-4. Day 1 Von Kossa Staining of preosteoblast cells on collagen matrices with
hydrogel nanoseed constructs. A) Well 1 with alginate-only hydrogels B) Well 2 with
alginate+ HNT+ BMP 2 C) Well 3 alginate+ CPC + HNT D) Well 4 alginate + CPC+
HNT+ BMP 2 E) Well 5 alginate+ CPC+ Chitosan lactate + HNT F) Well 6 alginate+
CPC+ Chitosan lactate + HNT+ BMP 2.
Image A shows cells that have attached and are proliferating on the collagen gel
matrix in the well containing the alginate-only hydrogel control bead. The experimental
groups are shown in images B-F. The cells in these images are also well attached and are
proliferating, suggesting that the collagen gel matrices provide a conducive environment
for cellular growth and that no inhibitory effect is seen on Day 1.
Figures 5-5 (A-L) show the Von Kossa staining for Day 3 for the alginate
hydrogel composite constructs.

Ill
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Figure 5-5. Day 3 Von Kossa staining of the preosteoblast cells on collagen matrices
with hydrogel nanoseed constructs. A) Well 1 with alginate-only hydrogels, site of initial
seeding B) Well 1 with alginate-only hydrogels, center C) Well 2 with alginate+ HNT+
BMP 2, site o f initial seeding D) Well 2 with alginate+ HNT+ BMP 2, center E) Well 3
alginate+ CPC+ HNT, site of initial seeding F) Well 3 alginate+ CPC + HNT, center G)
Well 4 alginate + CPC+ HNT+ BMP 2, site of initial seeding H) Well 4 alginate + CPC+
HNT+ BMP 2, center I) Well 5 alginate+ CPC+ Chitosan lactate + HNT, site of initial
seeding J) Well 5 alginate+ CPC+ Chitosan lactate + HNT, center K) Well 6 alginate*
CPC+ Chitosan lactate + HNT+ BMP 2, site o f initial seeding L) Well 6 alginate+ CPC+
Chitosan lactate + HNT+ BMP 2, center.
Figure 5-5 (A and B) show the cells in the control group. The cells have started to
differentiate and are producing calcium phosphate deposits at the site of injection seen as
small brown-black spots in image A. There is no migration towards the bead, as seen in
image B. Figure 5-5 (C and D) show the cells in well with alginate* HNTs+ BMP 2.
Image C shows larger brown-black spots at the site of injection suggesting differentiating
cells. Image D shows the center o f the matrix with differentiating cells and brown
patches.
Figures 5-5 (E and F) show the differentiating cells in well with alginate+ CPC*
HNTs producing calcium phosphate (brown spots) at the site of injection (E) and no
migration of the cells (F). Figure 5-5 (G and H) shows the differentiating cells in well
with alginate* CPC* HNTs* BMP 2. Image G shows the differentiating cells producing
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calcium phosphate as brown patches at the site of injection. Image H shows the migrating
cells which are differentiating at the center of the collagen gel matrix producing calcium
phosphate deposits as brown patches.
Figures 5-5 (I and J) show the differentiating cells in the well with alginate+
CPC+ Chitosan lactate+ HNTs. Image I shows differentiating cells producing calcium
phosphate deposits as brown patches and no migration towards the bead as seen in image
J. Figures 5-5 (K and L) show the differentiating cells in the well with alginate+ CPC+
Chitosan lactate+ HNTs+ BMP 2. Image K shows the differentiating cells producing
calcium phosphate seen as brown spots and image L shows the migrating and
differentiating cells producing the calcium phosphate deposits. Overall, Figure 5-5
shows that most calcium phosphate production takes place in the well with the
differentiating cells in the well with alginate+ CPC+ Chitosan lactate+ HNTs+ BMP 2 (K
andL).
Figure 5-6 (A-L) shows the Von Kossa staining for Day 7 for alginate hydrogel
composites or nanoseeds.
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Figure 5-6. Day 7 Von Kossa staining of the preosteoblast cells on collagen matrices
with hydrogel nanoseed constructs. A) Well 1 with alginate-only hydrogels, site of initial
seeding B) Well 1 with alginate-only hydrogels, center C) Well 2 with alginate+ HNT+
BMP 2, site o f initial seeding D) Well 2 with alginate+ HNT+ BMP 2, center E) Well 3
alginate+ CPC + HNT, site of initial seeding F) Well 3 alginate+ CPC + HNT, center G)
Well 4 alginate + CPC+ HNT+ BMP 2, site of initial seeding H) Well 4 alginate + CPC+
HNT+ BMP 2, center and near bead (insert) I) Well 5 alginate+ CPC+ Chitosan lactate +
HNT, site o f initial seeding J) Well 5 alginate+ CPC+ Chitosan lactate + HNT, center K)
Well 6 alginate+ CPC+ Chitosan lactate + HNT+ BMP 2, site of initial seeding L) Well 6
alginate+ CPC+ Chitosan lactate + HNT+ BMP 2, center and near bead (insert).
Figure 5-6 (A and B) show the differentiating cells in the control well. The cells
have produced calcium phosphate deposits at the site of injection (A) and cells have not
migrated towards the control bead (B). Figure 5-6 (C and D) shows the differentiating
cells in the well with alginate+ HNTs+ BMP 2. The cells have produced calcium
phosphate seen as brown spots at the site of injection (C) and at the center of the collagen
gel matrix by the cells that have migrated towards the bead (D).
Figure 5-6 (E and F) shows the differentiating cells in the well with alginate+
CPC+ HNTs. The cells at the site of injection have produced calcium phosphate deposits
that are seen as dark brown or black patches (E) and no migration seen towards the bead
(F). Figure (G and H) shows the differentiating cells in the well with alginate+ CPC+
HNTs+ BMP 2. The cells at the site of injection have produced calcium phosphate
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deposits (G) the cells have migrated and differentiated towards the bead in response to
the BMP 2 (H and the insert).
Figure 5-6 (I and J) shows the differentiating cells in the well with alginate+
CPC+ Chitosan lactate+ HNTs. The cells produce dark brown stained calcium phosphate
deposits at the site o f injection (I) and the cells have not migrated towards the bead as can
be seen in image J. Figure 5-6 (K and L) shows the differentiating cells in the well with
alginate+ CPC+ Chitosan lactate+ HNTs+ BMP 2. The cells at the site of injection (K)
and the migrating cells (L and insert) show calcium phosphate production seen as dark
brown patches.
As seen in all of the figures above, cells differentiate after Day 3 in all the wells at
the site of injection but migrate and differentiate towards the hydrogel beads or
nanoseeds with BMP 2 in the HNTs. This suggests that the alginate hydrogel composites
without BMP 2 are not chemoattractants.
The observations from both the histochemical staining experiments (Alcian Blue
and Von Kossa) suggest that alginate hydrogel composites enhanced with HNTs with
BMP 2 can act as chemoattractants and induce cellular migration and differentiation in
vitro. The observations from the histochemical staining experiments suggest that the
nanoseeds have potential to be used as implant material for bone regeneration. The
following subsections will further illustrate if the alginate hydrogel constructs
(nanoseeds) have the potential to function as implant materials.
5.3.1.3

Preosteoblast pilot study on the composite hvdrozels. A pilot study of

seeding preosteoblasts directly on composite hydrogel films with HNTs but without any
growth factors was done to see if the alginate hydrogels enhanced with CPC, chitosan
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lactate, and HNTs have any effect on the cellular differentiation. The study was done
for a 14 day period and the samples were taken for histochemical staining on Days 3,7,
and 14. The hydrogel composite films with the preosteoblasts were stained with
histochemical stains Alcian Blue and Picrosirius Red and then these films were
destained as described in the methods section. Figure 5-7 shows the Alcian Blue
staining and quantitative analysis by Nanodrop 2000 spectrophotometry.

■ CPC+Alginate
■ CPC+Alginate+Chitosan
■ CPC+Alginate+Chitosan+HNTs

Figure 5-7. Graph showing the absorbance (at 450-495 nm) of the eluted Alcian Blue
stain against the number o f days and different hydrogel composition. (n=6), p<0.05. Error
bars show standard deviation.
The graph in Figure 5-7 shows the absorbance of the eluted Alcian Blue
stain against the number o f days for different hydrogel composites. Alcian Blue
staining results shows that the CPC + alginate films had synthesized a greater
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amount of proteoglycan Day 3 (Mean: 1.93158) but there was a drop by Day 14
(Mean: 1.22901). The CPC + alginate films also had comparatively more ECM
than the rest o f the films as shown in Figure 8 on Day 3. The CPC+ alginate+
Chitosan films maintained ECM levels relatively equal on Days 3 (Mean: 1.7848),
7 (Mean: 1.89605) and 14 (Mean: 1.6552). The CPC+ alginate+ Chitosan+ HNTs
films had the least ECM polysaccharides on Day 3 (Mean: 1.586) when compared
against the other scaffolds. The levels of ECM polysaccharides decreased on Day 7
(Mean: 1.25685) but remained relatively similar on Day 14 (Mean: 1.3081).
Picrosirius Red staining was done for estimating the amount of collagen produced
by the cells on the hydrogel composite films. Figure 5-8 shows the Alcian Blue staining
and quantitative analysis by Nanodrop 2000 spectrophotometry.

■ CPC+Alginate
■ CPC+Alginate+Chitosan
■ CPC+Alginate+Chitosan+HNTs

Figure 5-8. Graph showing the absorbance (at 620-750 nm) of the eluted Picrosirius Red
stain against the number o f days. (n=6), p<0.05. Error bars show standard deviation.
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Figure 5-8 shows the graph o f absorbance o f the eluted Picrosirius Red stain
against the number o f days for different hydrogel composites. Picrosirius Red
staining data showed that the CPC+ alginate films had accumulated the less amount
of collagen on Day 3 (Mean: 1.35) but increased by Day 7 (Mean: 2.46) with a
decrease noted on Day 14 (Mean: 1.74). The CPC+ alginate films also had
produced a lesser amount o f collagen when compared with the other two coatings
(Figure 9). In contrast, CPC+ alginate+ chitosan films produced an initial higher
amount of collagen (Mean: 2.1781), which increased on Day 7 (Mean: 2.97) and
remained somewhat similar through Day 14 (Mean: 2.9198). CPC+ alginate+
chitosan+ HNT films produced the most collagen by Day 3 (Mean: 2.74) when
compared against the other scaffolds. The levels of collagen increased slightly on
Day 7 (Mean: 2.9196) and decreased in amount by Day 14 (Mean: 2.30). The
cumulative supports the observation that cells on all substrates produced a base
organic extracellular matrix.
A two ANOVA with replacement was used to check for the significance of the
results at a=0.05 for both the experiments (Alcian Blue and Picrosirius Red assays). The
statistical analysis was conducted by using MS Excel 2013 Toolpak® The statistical
analyses showed that there was significance across the days and across the groups with
CPC+ alginate and CPC+ alginate+ Chitosan + HNTs for Alcian Blue staining as
suggested by the higher F-stat values against F-critical values. There was also a
significant interaction within the groups across days suggesting that the trend seen in the
graph is significant. For Picrosirius Red staining there was significance observed for the
group CPC+ alginate+ Chitosan for all the three days as suggested by the higher F-stat
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values against F-critical values. There was also a significant interaction within the groups
across days suggesting that the trend seen in the graph is significant.
The cumulative observation of both the stain elution studies suggests that all the
hydrogel composites support the ECM and collagen production on all days. A
relationship was observed between the two graphs of stain elution studies for ECM
mucopolysaccharides and collagen production throughout the 14 day period. While the
cells on CPC/alginate produced more ECM mucopolysaccharides on Day 3 the cells on
other groups namely, CPC/alginate+ Chitosan and CPC/alginate+ Chitosan+ HNTs,
synthesized more collagen. The production of ECM mucopolysaccharides and collagen,
both are important for the differentiating cells as this is the organic template for the
formation o f new bone.
Looking at both the graphs (Figures 5-7 and 5-8), CPC/alginate+ Chitosan was
the composition that produced both ECM mucopolysaccharides and collagen in relatively
stable amounts throughout all the days. The next composition to follow is CPC/alginate+
Chitosan+ HNTs which produced comparable amounts of ECM mucopolysaccharides
and collagen on Days 7 and 14.
5.3.2

Release Study o f BMP 2 from HNTs and Various Hydrogel Composites
In the previous project, the release profile of BMP 2 from HNTs was studied. In

the current project, the objective of studying the release profile of BMP 2 was to
determine if it is released out of the hydrogel matrix and the concentration of the released
BMP 2. This would suggest that the BMP 2 is indeed, released out of the hydrogels and
not just out o f the HNTs and would suggest the hydrogel constructs have chemoattractant
potential.
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5.3.2.1

Release profile o f BMP 2 from HNTs. The release profile study of BMP 2

from HNTs was repeated to check the reproducibility of the release profile experiment
observations from the previous nanoenhanced bioactive hydrogels project. The
experiments were repeated for a period of 24 hours and 7 days. Figure 5-9 shows the
calibration curve for BMP 2 standards.
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Figure 5-9. Calibration curve for BMP 2 standards with absorbance (OD) and the
corresponding concentrations.
Figure 5-9 shows the calibration curve for BMP 2 standards that were used to
calculate the concentration of BMP 2 released from the HNTs and hydrogels. Figure 5-10
shows the conversion for the absorbance values and the corresponding concentrations.
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Figure 5-10. Graph for conversion for the absorbance OD values to corresponding
concentrations.
Figure 5-10 shows the graph with the conversion for the absorbance to
concentration. Figure 5-11 shows the BMP 2 release from HNTs for 24 hours.
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Figure 5-11. Graph showing release o f BMP 2 from the HNTs for 24 hours.
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The graph in Figure 5-11 shows that the results of the release profile of BMP 2
from the previous study are reproducible as they are comparable. The release of BMP 2
from HNTs is sustained for a period of 24 hours. The objective of this study was to
confirm that the growth factor is released into the hydrogel matrix and the graph shows
the release for a period of 24 hours. The error bars represent the standard deviation
calculated by the standard deviation of the data point and the average of the triplicate
samples (detailed process of calculation of the standard deviation described in Appendix
B). [59]
As described earlier, the release profile of BMP 2 for 24 hours was estimated by
the use o f custom made sandwich ELISA kits. The trend seen here is not o f the
cumulative release but that of individual data points. The concentration seen in the graph
cannot be regarded as accurate estimate as the standards provided by the manufacturer
showed resolution problems. The data should be viewed cautiously and regarded as a
qualitative estimate of the protein released from the HNTs. The raw data tables and
supplementary tables are provided in Appendix B.
The study was extended to a period of 7 days to check if the growth factor is
released for extended periods form the HNTs. Figure 5-12 shows the graph of release
profile o f BMP 2 from HNTs for 7 days.
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Release of BMP-2 (7 days)
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Figure 5-12. Graph showing the release profile of BMP 2 from HNTs for 7 days.
Figure 5-12 shows the graph for BMP 2 release profile from HNTs for a 7 day
period. This graph validates that the results obtained in previous study are reproducible
and also confirms that the HNTs release the growth factor in the hydrogel matrix for an
extended period of 7 days. The calibration curves used for the calculation of the values
are die same given in Figure 5-9 and 5-10. The release of the growth factor is in
nanograms per ml range. The error bars represent the standard deviation calculated by the
standard deviation of the data point and the average of the triplicate samples (detailed
process o f calculation o f the standard error described in Appendix B). [59]
The release profile of BMP 2 from the HNTs suggests that an extended and
sustained release can be obtained from HNTs for a period of 7 days. The release is in pico
and nanograms range which is the effective range for BMP 2 in natural tissue
environment. Even though the concentrations cannot be regarded as accurate due to the
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resolution error in the kit, especially below the concentration of 50 pg/ml, the qualitative
trend shows that the range in which the BMP 2 is released is comparable to the effective
range in natural tissues. The results obtained for 7-day release are encouraging as the
cellular differentiation process peaks at Day 7. Hence, a sustained release of BMP 2 for a
period of 7 days from HNTs is beneficial for early onset of cellular differentiation which
might lead to accelerated regeneration of the damaged bone tissue.
Release profile o f BMP 2 from HNT enhanced hvdroeels. The release profile

5.3.2.2

study o f BMP 2 from hydrogels enhanced with HNTs was carried out to investigate if
the BMP 2 was released from the hydrogels into the surrounding medium. The study
was conducted for a period of 36 hours.
Figure 5-13 shows the release profile graph of BMP 2 from hydrogels enhanced
with growth factor loaded HNTs.
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Figure 5-13. Graph o f release profile o f BMP 2 from hydrogels enhanced with HNTs.
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Figure 5-13 shows the release profile of BMP 2 from the HNTs in hydrogel
matrix. The calibration curves used are the same used in Figure 5-9 and 5-10. The graph
shows a qualitative trend and the concentrations are not accurate as mentioned earlier due
to the resolution problem and noise in the standards of the kit.
The trend shows an extended and sustained release can be observed for a period
of 36 hours in the above graph. This result supports the observation that the cells
migrated towards the nanoseeds (Nanoenhanced hydrogels with BMP 2 loaded HNTs)
placed at one end o f the collagen gel matrix in Section 5.3.1. The growth factor is
released out o f the gel matrix serving as the chemoattractant signal.
It would have been ideal to have a release profile for 7 days. The experiment
could be performed only for a period of 36 hours or three days as the hydrogels broke in
the HBSS solution due to continuous rocking of the platform. The error bars represent the
standard deviation calculated by the standard deviation of the data point and the average
o f the triplicate samples (detailed process of calculation of the standard deviation is
described in Appendix B). [59]
5.3.3

FE-SEM Imagine and Comparison of the Hydrogel
Composites Surface Morphologies
FE-SEM imaging was done to understand the differences between the surfaces of

die alginate hydrogels when enhanced with CPC, Chitosan lactate, and HNTs. It is
important to understand how the surfaces are modified by the addition o f the composite
materials as this will shed light on the material interactions and some o f the material
properties that are altered. Figure 5-14 shows a general comparison o f the surfaces and
overall morphology o f the hydrogel beads with addition of the composite materials at
lower and higher magnification.
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Figure 5-14. A comparison of different hydrogel constructs surface morphologies at
higher magnification.
Figure 5-14 shows a general overview of the surface morphologies of the alginate
hydrogel composite beads. The lower magnification images show the overall
morphologies o f the hydrogel beads. The alginate-only bead has smooth surface and
looks shriveled compared to the rest of the hydrogel composites. The hydrogel beads with
HNTs, CPC, and chitosan lactate have retained their size and shape even after
lyophilization and have rough surfaces. The bead with alginate+ CPC+ chitosan lactate
has the most rigid and well retained structure after lyophilization. The ridges and surface
features are uniform and well defined in this composition of the hydrogel composite.
The higher magnification images in Figure 5-14 show the corresponding surfaces
in details for the respective alginate hydrogel composite compositions, alginate-only
hydrogel shows a relatively smooth surface devoid of any surface features. The alginate+
HNTs and alginate+ CPC hydrogels have relatively rough surface. The most well defined
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surface features can be seen in the higher magnification image of alginate+ CPC+
chitosan lactate bead with well-defined ridges and grooves. These images provide a
general understanding of how the surfaces get modified by the addition of composite
materials. Figure 5-15 (A-D) shows the surface topography of the alginate composites in
greater details at higher magnifications.
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Figure 5-15. FE-SEM images of A) alginate-only B) alginate+ HNTs C) alginate+ CPC
and D) alginate+ CPC+ Chitosan showing the surface morphology at 100 pm
magnification.
Figure 5-15 (A and B) show the FE-SEM images of alginate-only and alginate+
HNTs hydrogel beads at 100 pm scale. The surface of alginate-only hydrogel (control)
looks smooth and there are no ridges or grooves on the surface. There are only slight
elevations with few pores visible in the image. The surface of the hydrogel with HNTs
shows a relatively rough surface with small and sharp mound like elevations protruding
out of the surface. No pores or ridges and grooves are visible in the image.
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Figure 5-15 (C and D) show the FE-SEM images of alginate hydrogels enhanced
with CPC (C) and CPC+ Chitosan lactate (D). The surface alginate+ CPC hydrogel
shows distinct ridges and grooves and some pores sunken in the surface. The elevations
protruding out o f the surface look uniform giving a well-defined appearance to the
surface of the bead (C). The surface of the alginate+ CPC+ chitosan lactate bead shows
longer elevations as compared with alginate+ CPC hydrogel bead. Ridges and grooves
are not visible at this magnification but pores can be seen on the mound shaped
elevations (D). The surface also appears to be rougher when compared to surfaces of
alginate-only and alginate+ HNTs hydrogel beads (A and B). Figure 5-16 shows the
surface topography of the alginate hydrogel composites at higher magnification (10 pm)

Figure 5-16. FE-SEM images of A) alginate-only B) alginate+ HNTs C) alginate+ CPC
and D) alginate+ CPC+ Chitosan showing the surface morphology at 10 pm
magnification.
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Figure 5-16 (A-D) shows FE-SEM images o f the alginate hydrogel composite
surfaces at higher magnification (10 pm scale). The surface of the alginate-only hydrogel
(A) shows an area o f rough surface surrounded by smooth surface. This rough surface
looks sunken into the bead and might have resulted out of scratch during handling o f the
bead. alginate+ HNTs hydrogel (B) shows relatively smaller elevations and HNTs
sticking out of the surface. The alginate+ CPC hydrogel (C) surface looks crumpled and
has sharp ridge like elevations. The alginate+ CPC+ Chitosan lactate (D) surface shows
similar elevations as seen in image C but the elevations are larger.
Comparing all the images from Figures 5-14, 5-15, and 5-16, the observations
suggest that addition of composite materials like HNTs, CPC, and chitosan lactate
modifies the surface o f alginate hydrogels and makes it rougher with surface features like
elevations, ridges, and grooves. The modification of surface might be beneficial for
cellular attachment as cells will find a favorable surface to anchor themselves on to the
hydrogels. The enhancement of alginate hydrogels with the composite materials will
make the hydrogels more suitable as implant materials.

CHAPTER 6
HYDROGEL COATINGS FOR TITANIUM IMPLANTS
6.1

Introduction

Severe bone injuries have been secured by orthopedic implants for over fifty
years. [48] Stainless steel was replaced by titanium became of its excellent
biocompatibility. [48] Titanium and its alloys do not corrode as seen in stainless steel and
other metal alloys. [48] It is relatively inert and has suitable material properties that make
useful for stabilizing broken bone fragments. [48] Despite of its virtues, titanium faces
certain drawbacks such as it failure to osteointegrate with surrounding bone tissue and it
is prone to post-surgical infections. [20,26, 37]
Post-surgical infections are one of main causes o f the titanium implant failure.
[20,26, 37] In worst case, the implant needs to be completely removed from the body,
the surrounding tissue debrided and cleaned, and a new implant be inserted at the site of
injury. [35] This procedure can lead to complications due to patient’s physiological state,
health status, age, and clinical condition.
In the previous chapters (Chapters 4 and 5), the applications of calcium alginate
and composite hydrogels have been discussed in detail. In the current chapter, the
application o f bioactive hydrogels enhanced with CPC, chitosan lactate and HNTs loaded
with anti-infective drug, gentamicin sulfate, is discussed. Gentamicin sulfate (henceforth
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referred to as GS) is widely used in the field of orthopedic medicine to treat infections
from gram-negative strains o f bacterium. [38]
The primary hypothesis of this project was to develop anti-infective hydrogel
coatings for titanium implants that will inhibit the growth of gram negative bacterium, E.
coli, in this study. The secondary hypothesis was to investigate if anodization of the
surface retains or enhances the osteogenic properties of titanium by laying hydroxyapatite
foundation to make it favorable to the osteogenic cells and enhancing its osteointegration.
The graphical representation in Figure 6-1 below shows the objectives and the construct
with anodized titanium and anti-infective hydrogel.

Figure 6-1. Graphical representation of the anti-microbial hydrogel (H) coating applied
to anodized titanium (AT). From left to right, bacteria (B) encounter the anti-microbial
hydrogel and released gentamicin (G) altering their metabolism leading to cell death. T =
titanium.
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6.2

M aterials and Methods

Plasticware was obtained from Mid Scientific, St. Louis, MO. All chemicals for
synthesis, physical, and chemical analysis were purchased from Sigma Aldrich, St. Louis,
MO. Gentamicin disks were obtained from Thermo Scientific, Waltham, MA. Titanium
sheets (foils o f thickness 0.1 mm) were obtained from Sigma-Aldrich, St. Louis, MO.
6.2.1

Anodization o f Titanium
The anodization apparatus was set up in CTH 316. The details of the procedure

for anodization are described in Section 3.1.7. Anodization for the titanium sheets was for
1 ,2 ,3 , and 4 minutes. The difference in the surface of the sheet for the different time
durations was analyzed by FE-SEM.
6.2.1.1

SBF study on the osteogenic properties o f anodized titanium. To ascertain

whether titanium retains its osteogenic potential after anodization, the sheets anodized
for different time duration were kept immersed in simulated body fluid (SBF) for seven
days. The SBF was replaced every day for the duration o f the experiment. After seven
days the sheets kept in SBF were gently washed and air dried for imaging under FESEM. EDX analysis was performed for elemental analysis.
6.2.2

Bacterial Inhibition Study on the GS-HNT Enhanced Hydrogel Constructs
The hydrogels enhanced with GS loaded HNTs were tested for their bactericidal

properties on Muller-Hinton agar plates. The bacterial studies were carried out for 24
horns. If the bacteria fail to grow within the immediate 24 hours, the chances o f postsurgical infection due to the implant are reduced. [26,38,39,52] The details of the
bacterial inhibition studies are given in Section 3.2.7.
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6.2.3

Release Profile Study of GS from HNTs and Hvdroeels
Enhanced with HNTs
A release profile study was conducted for both the hydrogels and HNTs to

estimate the amount o f GS released from them. The release profile procedure is explained
in details in Section 3.2.6.

6.3

Results and Discussion

This section discusses the results from the experiments from the previous section
from the current chapter.
6.3.1

FE-SEM Imaging of the Anodized Titanium
The anodized and non-anodized titanium were imaged by FE-SEM to analyze the

difference between their surfaces. Figure 6-2 shows the anodized titanium surfaces after 1
minute, 2 minutes, 3 minutes, and 4 minutes and non-anodized titanium (control) for
comparison.
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Figure 6-2. Titanium surfaces after anodization at 5|im magnification A) 1 minute B) 2
minutes C) 3 minutes D) 4 minutes and E) Non-anodized titanium (control) at 10 jim
magnification.
Figure 6-2 (A) shows titanium after 1 minute of anodization. The surface is not
visibly modified and looks similar to the control in Figure 6-2 (E). The surface
modification by anodization visibly shows after 2 minutes (B-D) and is significantly
different in titanium anodized for 4 minutes (D). The observations from the images in
Figure 6-2 (A-E) suggest that the titanium surface gets etched and modified after 2
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minutes o f anodization. Further analysis of properties of the anodized titanium was done
by immersing the anodized titanium in SBF for 7 days as described in the following
section.
6.3.1.1

FE-SEM imagine and ED X o f the SBF- titanium study. The SBF-titanium

study was done to investigate if the osteogenic properties of titanium were retained
even after anodization. This study is important to assess how anodization of titanium
affects its osteogenic properties. If the osteogenic properties get enhanced, as suggested
by larger and more deposits of hydroxyapatite crystals on the anodized titanium
surface, then this would suggest that anodization would improve the biological
properties of titanium and help in better integration of the implant in the host tissue.
Figures 6-3 and 6-4 show the results o f EDX analysis for the titanium sheets kept
immersed in SBF for 7 days. Figure 6-3 shows the EDX analysis report for control sheet
(Non- anodized titanium).

Z H f'.M U ttfk M

Um: M

KCM

TiK
M atrix

100.00

Figure 6-3. EDX analysis of control titanium sheet in SBF for 7 days.
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Figure 6-3 shows the graph and analysis report o f the EDX analysis for the nonanodized titanium sheet after immersion in SBF for 7 days. Although visual inspection
showed a thin powdery layer on the titanium sheet, the EDX could not detect any other
element such as calcium, phosphorous, or oxygen on the surface of the sheet. The
elemental analysis shows only titanium which is the component o f the sheet. This
analysis suggests that the deposition o f hydroxyapatite on the sheet was negligible or was
too low for the EDX to detect. Figure 6-3 shows the EDX analysis report for titanium
anodized for 4 minutes and immersed in SBF for 7 days.
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Figure 6-4. EDX analysis of 4 minutes anodized titanium in SBF for 7 days.
Figure 6-4 shows the EDX elemental analysis of the 4-minute anodized titanium,
showing the peaks for calcium, phosphorous, oxygen, and other elements. The significant
deposition o f calcium, phosphorous, and oxygen suggest that hydroxyapatite crystals
were formed on the surface after 7 days. Only 4-minute anodized titanium sheet was used
for the EDX analysis as the cost for running one sample was high and the observations
from Section 6.3.1, suggested that 4 minute anodized sheets had significantly modified
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surface, compared to other anodized surfaces and the control. A visual comparison can be
done in Figures 6-3 and 6-4 for other anodized titanium sheets and the control sheet (nonanodized titanium) immersed in SBF for 7 days.
Figure 6-5 shows the FE-SEM images for the surface morphology and
hydroxyapatite crystal depositions on non-anodized titanium (control) and 4-minute
anodized titanium.
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Figure 6-5. FE-SEM images o f A) non-anodized and B) 4 minute anodized titanium after
7 days in SBF with the marked area showing hydroxyapatite crystal at 50 pm.

Figure 6-5 shows the smooth surface of non-anodized titanium (A) with small
deposits o f hydroxyapatite crystals shown by arrows. The surface of 4 minute anodized
titanium shows a rough and porous surface with a big chunk o f hydroxyapatite crystal
marked by the circle. Figure 6-6 shows FE-SEM images of the 1-minuut through 4minute anodized titanium immersed in SBF for 7 days at higher magnification.
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Figure 6-6. FE-SEM images showing the different surfaces of titanium and the
hydroxyapatite crystals after immersing in SBF for 7 days at 2 pm A) Control- Nonanodized titanium B) 1 minute anodized titanium C) 2 minutes anodized titanium D) 3
minutes anodized titanium E) 4 minutes anodized titanium.
Figure 6-6 (A-E) shows the surfaces of the anodized and non-anodized titanium
immersed in SBF after 7 days. All the anodized titanium sheets show deposition of white
powdery spikes which are calcium phosphate or hydroxyapatite crystals (B-E). Non-
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anodized control (A) shows a thin layer of white powdery mass on its surface but it is not
as prominent as the crystals seen on the surfaces on the anodized titanium sheets (B-E).
The 1-minute anodized sheet (B) shows larger spikes or hydroxyapatite crystals
and the 2, 3, and 4 minute anodized sheets (C-E) show numerous small crystals on their
surfaces. The visual comparison suggests that anodization carried for different durations
modify the surfaces by producing different degrees of roughness and pores. This renders
different surface properties to the titanium sheets leading to the formation of
hydroxyapatite crystal deposits that are of different sizes and shapes. These crystals may
be deposited in varying densities as seen in 1-minute anodized titanium sheet (B) and in
4-minute anodized titanium sheet (E). The increased deposition o f calcium phosphate
(hydroxyapatite) on the surfaces of the anodized titanium suggests that anodization might
improve the osteogenic and osteointegrative properties of titanium making it a better
implant material.
6.3.2

Bacterial Inhibition Study on the GS-HNT
Enhanced Hvdroeel Constructs
Bacterial inhibition study was done with the GS-HNT enhanced hydrogel

constructs to investigate if the anti-infective properties o f GS are retained after loading in
die HNTs and encapsulation within the hydrogels. This study would also investigate the
anti-infective capabilities of GS-HNT enhanced hydrogels. Figure 6-7 shows the image
o f negative control, LB agar plate with no bacterial colonies and no anti-infective agent
GS on it after 24 hours. Sterile conditions were maintained throughout the duration of the
study and plate was incubated at 37 °C.

Figure 6-7. Negative control plate with no bacteria and/ or anti-infective agent GS.
Figure 6-8 shows the image o f positive LB agar plate with bacterial colonies or
lawn and without the anti-infective GS after 24 hours o f inoculation.

Figure 6-8. Positive control plate with bacterial lawn and no anti-infective agent GS.
Sterile conditions were maintained for the duration of the study and the plate after
inoculation was incubated at 37 °C. The bacterial lawn is continuous without any breaks
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or irregular empty patches. This continuity suggests that the bacteria used in the study
were healthy and could readily form colonies on the nutrient plates after inoculation.
Figure 6-9 (A-D) shows the images of the plates for bacterial inhibition study for antiinfective hydrogel constructs.
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Figure 6-9. Bacterial growth inhibition studies (A) Alginate+ HNTs+ CPC+ chitosan,
alginate* HNTs* CPC, alginate-only, and alginate* HNTs on LB agar plate. (B)
Gentamicin control disk (60 mg gentamicin) shows a large zone of inhibition, (b) E. coli
growing as a continuous lawn.(C) Mueller-Hinton plate with hydrogels with gentamicin
sulfate showing zones o f inhibition (top) alginate* HNTs* CPC* chitosan* gentamicin,
(bottom) alginate* HNTs* CPC* gentamicin, (D) alginate* HNTs* gentamicin, (n=6).
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Figure 6-9 (A) shows the different compositions of the alginate hydrogels without
anti-infective GS in the individual quadrants on a lawn of bacteria after 24 hours of
inoculation. The hydrogels without GS do not form zones of inhibition on the bacterial
lawn, as they do not possess anti-infective properties themselves. Figure 6-9 (B) shows
GS standard disk (60 mg gentamicin) in first half area of the plate serving as positive
control. The disk produces a distinct zone o f inhibition on the bacterial lawn which is
about 2 cm in diameter (measured form the center of the disk) after 24 hours of
inoculation. The other half area of the plate shows a continuous lawn of bacteria growing
without any irregular empty patches after 24 hours of inoculation that served as the
negative control. Images in Figure 6-9 (C and D) show the hydrogels with gentamicin
sulfate after 24 hours o f inoculation. The images show zones of inhibition (top) alginate*
HNTs* CPC* chitosan* GS, (bottom) alginate* HNTs* CPC* GS in image C, and
alginate* HNTs* GS in image D. The zones of inhibition in both the images are about 2
cm in diameter suggesting that the GS released from the HNTs in the hydrogels inhibited
the growth of the bacteria on the LB agar plate and have diameter comparable to the GS
standard disk in the positive control. The results from the images of the bacterial
inhibition study suggest that GS can inhibit the growth of the bacteria and retains its antiinfective properties after it is loaded into HNTs and encapsulatied into hydrogels.
To further quantify the bacterial colony-forming units (CFUs) on the control and
experimental plates, we used an image analysis software called O penC Fl/5to count the
CFUs. The results are summarized in Table 3.
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Table 3. Results of image analysis of the bacterial plates
Plate

No. of CFUs

Negative control

NA

Positive control

765
Outside zone of inhibition

Near the beads

Alginate+ HNTs+ GS

422

16

Alginate+ CPC+/-Chitosan+
HNTs+GS

998

11

The numbers of CFUs near the beads containing GS loaded HNTs were small
compared to the number o f CFUs growing on the agar plate away from the zone of
inhibition as can be seen in the summarized results in Table 3. The number was not zero
as the regions of interest selected also included the peripheries of the zone o f inhibition
where the boundaries are not sharply defined.
6.3.3

Release Profile Study of GS from HNTs and Hvdroeels
Enhanced with HNTs
The release profile study of GS-loaded HNTs and of hydrogel composites

enhanced with GS-loaded HNTs was performed to estimate the amount of GS released
from HNTs and hydrogels.
The release study for GS from HNTs was done for a period of 7 days. Figure 6-10
shows calibration curve for GS used to calculate the concentrations for GS released from
HNTs for 7 days.
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Figure 6-10. Calibration curve for GS used to calculate GS concentrations released from
HNTs for 7 days (n=6).
Figure 6-10 shows a calibration graph of absorbance versus concentration (mg/
ml). This graph gives the corresponding values for GS released from HNTs at a particular
absorbance. Figure 6-11 shows the cumulative release of GS from HNTs for 7 days.

146

GS release from HNTs
0.8
0.7
■i

0.6

mm

1
£
c

"efc 0.5

~

0.4 •

2
4->
c

vu

c

r0.3
\ o

'

uo
0.2

01 {
0

0

20

40

60

80

100

120

140

Time (hrs)

Figure 6-11. The cumulative release of GS from HNTs for 7 days.
Figure 6-11 shows the cumulative release of GS from HNTs for 7 days. The
release for GS from HNTs was extended and sustained for a period of 72 hours and the
points after 72 hours reach a plateau, as can be seen from the graph. The release study
was repeated three times and each time the samples were collected in duplicates (n=6).
The release profile o f GS from the HNTs for a period of 7 days shows a release
characterized by an initial high burst of release within the initial 24 hours and a later little
additional release. The initial high burst of release within the initial 24 hours can be
attributed to the drug being coated on the outer surface as well as the drug loaded in the
lumen coming out as a high burst. The release of GS differs from that o f the BMP 2
molecule discussed in the previous chapters because of the size difference of the
molecules. BMP 2 is a protein and its molecular size is larger than Gentamicin sulfate
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which is an aminoglycoside. As most o f the drug comes off from the lumen within the
period o f initial 24 hours there is little drug coming out in the later stage of the study.
The cumulative release profiles of GS from HNTs in hydrogel composites were obtained
for a period o f 7 days. Figure 6-12 shows the cumulative release profiles of GS from
HNTs in hydrogel composites for 7 days. The error bars represent the standard deviation
calculated by the standard deviation of the data point and the average of the triplicate
samples (detailed process of calculation of the standard deviation described in Appendix
B). [59]
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Figure 6-12. Cumulative graph of gentamicin sulfate release from hydrogels showing
time (hours) vs. concentration (mg/ ml).
Figure 6-12 shows a cumulative release profile for GS from HNTs in hydrogel
composites for 7 days. The graph shows time (hours) versus concentration (mg/1) of the
GS released from the HNT enhanced hydrogel composite- alginate+CPC+HNTs+ GS
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(green squares) and compared against alginate+CPC+ 2% v/v GS (blue triangles) and
HNTs only (red rhombus). The calibration curve shown in Figure 6-10 was used to
calculate the concentrations of GS released. The error bars represent the standard
deviation calculated by the standard deviation of the data point and the average o f the
triplicate samples (detailed process of calculation of the standard deviation described in
Appendix B). [59]
The comparative study o f the cumulative release of GS from different constructs
shows that all the release profiles are defined by a characteristic initial high burst of drug
release in the initial 24 hours and a later small additional release. The initial high burst of
release within the initial 24 hours can be attributed to the drug being coated on the outer
surface as well as the drug loaded in the lumen coming out as a high burst. As most o f the
drug comes off from the lumen within the period of initial 24 hours there is little drug
coming out in the later stage of the study.
A comparison o f the initial high burst values of different constructs (CPC 2% GS
v/s HNTs and CPC-HNT GS) reveals that loading GS in HNTs might reduce the amount
o f GS being released in the initial 24 hours, extending the release to 48 hours. This
delayed release might be caused by the drug molecules being trapped in the inner lumen
and the concentric layers o f aluminosilicate and released in a slightly delayed manner.
For implants to be successful, formation of bacterial films on the surface o f the
implants has to be prevented. Usually, infection sets in within the first 24 hours. [38, 39,
40] For the prevention o f infection, first 24 hours after implantation are crucial and an
anti-infective needs to be supplied in a sustained manner over an extended period beyond
24 hours. The observations from Figures 6-7,6-8,6-9,6-11, and 6-12 suggest that the
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hydrogel composites enhanced with GS loaded HNTs would be a better anti-infective
delivery system as the anti-infective GS would be released for an extended period of 48
hours which would prevent the bacterial growth on the implants.

CHAPTER 7
CONCLUSIONS AND FUTURE WORK
Chapters 4 ,5 , and 6, discussed three projects with interrelated concepts and novel
application o f hydrogels, nanoparticles and anodized titanium. The cuirent chapter
synthesizes the recorded observations and integrates them with concepts from Chapters 4,
5, and 6. A plan for the future direction o f this work is also provided.
Chapter 4 discussed in detail the testing of the hypothesis that the addition of
HNTs and growth factors to alginate hydrogels will improve the hydrogels’ biological
performance and material properties. The observations from the results suggest that the
cells performed better in the alginate hydrogels with growth factor-loaded halloysites.
Among the three growth factors used (BMP 2,4, and 6), histochemical staining and
analysis revealed that alginate hydrogels with BMP 6 and BMP 2+ 0.4M ascorbate
medium performed better than the rest o f the groups. BMP 2 is FDA approved for use in
orthopedic and orthodontic applications. [13] Hence, it can be used in combination with
0.4 M ascorbate medium to yield best results with osteogenic response. The release of
BMP 2 from halloysite was sustained and extended suggesting that the growth factor can
be made available to the regenerating tissue throughout a seven day period, and at low
amounts, which is crucial for cellular differentiation and maturation.
The release o f BMP 4 and 6 could not be studied, as the customized kits for
ELISA are not available commercially. In future studies, the release profiles of BMP 4
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and 6 can be studied and compared to the release profile of BMP 2. These studies will
reveal the pattern o f release o f these growth factors from halloysite and hydrogels. The
behavior o f die cells and the formation of hydroxyapatite crystals after mineralization can
be studied by performing micro-CT (computational tomography) analysis on the
hydrogels with osteoblasts encapsulated in them. This analysis would provide
visualization o f the three dimensional constructs, orientation o f the cells and mineral
deposits after cellular differentiation.
Chapter 5 discussed in detail the concept of “nanoseeds” or Nanoenhanced
alginate hydrogel composites as potential chemoattractant materials. The primary
hypothesis was to test if these constructs could attract the Osteoprogenitor cells towards
them through molecular signaling by release of BMP 2. The histochemical analyses
showed that the cells in the wells with growth factor-loaded HNT enhanced alginate
hydrogel composites migrated towards the source of molecular signal, the hydrogel bead.
It can be concluded from the observations that the “nanoseeds” can act as
chemoattractants and can be used to accelerate the process of bone regeneration when
used in combination with metal implant materials. The material testing also revealed that
the material properties are altered by the addition of the composite materials (HNTs,
CPC, and chitosan lactate).
NucBlue fluorescent staining results were not included as the stain faded after
Day 3 of die migration study. The images for the NucBlue staining method were
inconclusive but the same wells when stained with histochemical stains such as Alcian
Blue and Von Kossa, showed that the cells had migrated from their site of seeding
towards the molecular signal (the hydrogel composite beads with BMP 2). In future
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studies, the modified behavior of the migrating cells can be studied at the molecular and
genetic level by performing PCR and western blots to visualize the levels of osteogenic
markers and gene segments expressed. To understand the material properties of the
composite hydrogels and the interaction between the materials, Nanoindentation studies
can be performed on the hydrogel constructs. Nanoindentation studies would quantify the
surface roughness and other material features of the hydrogel constructs. The pilot study
with the preosteoblasts being seeded directly on the composite hydrogel films can be
extended into a full study.
Chapter 6 described the surface modification of the titanium by anodization and
enhancing the alginate hydrogel composites with HNTs and GS (anti-infective agent).
The primary hypothesis o f the project was to improve the osteogenic properties of
titanium making it more osteointegrative and prevent the growth of bacteria on its
surface. The observations from the results showed that the osteogenic properties were
improved upon anodization with 4 minutes of anodization producing the most modified
surface and having the highest deposition o f calcium phosphate (hydroxyapatite crystals).
The bacterial inhibition studies showed that the alginate hydrogel composites with GS
could prevent the growth o f bacteria. It can be concluded from the observations that
anodization o f titanium and coating the surface of the metal with anti-infective hydrogels
would prevent the bacterial growth and improve its osteogenic properties.
Mammalian cellular studies with co-culture of bacteria can be performed in the
future, to assess the performance of anodized titanium coated with anti-infective hydrogel
coatings in simulated internal environment. In the future, the in vitro studies can be
extended to in vivo studies with animal models. Anodized titanium can be tested for
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cellular response by seeding osteoblasts directly on the metal surface for an extended
period o f 28 days or more. Bacterial inhibition studies can also be extended beyond 24
hours if the bacteria can be cultured for an extended period. The bacterial studies can be
done with other bacterial species like Staphylococcus.
All the above projects were tested in vitro due to time and resource constraints.
Future studies can extend these projects to in vivo testing on animal models. The scope of
all the projects in this dissertation was limited to the osteogenic aspect of bone
regeneration. The skeletal regeneration has other aspects like angiogenesis and bone
remodeling. These aspects can be studied in the future by selecting angiogenic growth
factors and conducting the studies on co-cultures containing skeletal cell lines (e.g.
myoblasts, osteoblasts, mesenchymal stem cells, and chondrocytes).
An investigative study on the effect o f growth factors, nanoparticles and hydrogel
composites on cell behavior with a comparison between murine bone cell lines and
human bone cell lines can help to predict the behavior of these constructs in humans as
implant materials. As with any research, the experimental design can be improved. The
experiments can be extended to 28 days, more advanced imaging techniques, like microCT, or mechanical testing, like Nanoindentation, can be used to quantify the results that
are discussed in this dissertation. The three projects indicate that the constructs hold
promise as potential implant materials that can overcome some limitations of the current
commercially available implant materials.
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IMAGE ANALYSIS
For quantifying the values of the intensities of RGB colors in the histochemically
stained hydrogel sections we used Image J® software. The software plotted graphs for
RGB peaks and grayscale intensity values. This image analysis was used to substantiate
the observations and inferences drawn in the histological staining images in Sections
4.3.1.1,4.3.1.2, and 4.3.1.3.
The method used in this dissertation for Image J image analysis can be
summarized as follows:

Open Image J

• Click on 'File'

In the drop down
menu click on
'Open' and select
the image to be
analyzed

Click on
'Analyze'
and select a
region of
interest
A graph of RGB
peaks and color
intensity will be
displayed.
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RELEASE STUDY PLOT AND ERROR BARS
The process o f release study and plotting the graphs can be summarized as

Sample
collection

At least 3 samples were collected for a particular time
point and stored in air-tight capped tubes at 4 °C

•The choice o f assay to perform to read the OD o f the sample
depends on the nature o f the sample.
•In case o f BMP 2 we used ELISA custom-made kits known for
Assay to calculate their high sensitivity (pg/ ml and ng/ml)
the optical density •In case o f Gentamicin we sued OPTA reagent assay and
UV/VIS spectrophotometry
(OD)

Recording
readings &
plotting graphs

•The readings were recorded as individual time points in MS Excel
worksheet as raw data. These data points were then averaged and
their averages were used to obtain the cumulative values for the
release.
•The cumulative values were the sum of the current data point
average and the previous data point average. E.g. If A, B, and C
are the averages o f the two data points then the cumulative release
points will be 1) A, 2) A+B, 3)A+B+C,...
•The cumulative values for release were then used to plot the
cumulative release graph.
• Standard error was used to estimate the error as it calculates the
accuracy o f the values with thier means.

follows:
In the article by Zheng et al., 2011 in the Journal of Dmg Delivery, the
authors describe four types of release profiles and describe the curve as either having
initial high/ low burst release or late little/ extended release. In this dissertation, we used
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this model to describe the release profiles of the growth factor BMP 2 and
antibiotic Gentamicin.
We chose to use standard deviation bars to represent the deviation from the
average of each point. The author uses averages and standard deviation for each point to
plot the error bars for the cumulative plot. The standard deviation is calculated as

where S.D. is the standard deviation of that point, .vis the data point, x is the average of
the readings and N is the number of samples taken for that point.
For calculating the concentrations we plotted a calibration curve for the respective
bioactive molecule by using known standards and their corresponding absorbance values.
The absorbance values shown by the experimental samples were then plotted using the
equations mentioned in the calibration curves to find the concentrations. The final graph
was the plot of the concentrations calculated from the calibration curves and the
corresponding time points. For the BMP 2 plot, the graph is not a cumulative plot but the
plot of individual data points and shows a general representation of the concentrations for
the particular time point.
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EXPERIMENTS WITH
INCONCLUSIVE RESULTS
AND FAILURES
The following is the list and a brief description of the experiments that were
conducted on the hydrogel constructs to investigate either their biological or material
properties which had inconclusive results or failed to perform in the given conditions.
1. NucBlue fluorescent staining assay.
^
♦ »
The NucBlue ' fluorescent staining assay was performed to visualize the cells in
collagen gel matrix for the Nanoseeds project. The cells were first stained with the
protocol provided by the manufacturers and then seeded on the collagen gel matrices.
The study was to be carried out for 7 days and with samples imaged on days 0, 3, and
7. The NucBlue stain is a vital stain and helps in visualization o f the cells without
requiring sample processing and fixing. The stain faded out after Day 3 and the
results were inconclusive as the migration of the cells towards the chemoattractant
hydrogel beads could not be visualized.
We had to rely on the histochemical staining (Alcian Blue and Von Kossa stains)
which had better visualization of the cells along with ECM materials and minerals to
study the cellular migration.
2. Nanoindentation of the hydrogel constructs.
The hydrogel composite samples were sent to University of Wisconsin, Milwaukee to
quantify and analyze their material properties like surface roughness, elasticity, and
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pore distribution by Nanoindentation technique. It was courtesy of Dr. Lobat Tayebi
who referred Dr. Steve Hardcastle as the point of contact and testing of the samples.
Dr. Hardcastle encountered difficulties in performing the Nanoindentation technique
on the hydrogels as the samples kept rupturing and the tip was not suitable to be used
on our samples. We were advised to obtain diamond tips and the study had to be kept
on hold due to the high cost of the tips and the tests.
1. Gradient Tech* cell migration study.
To study the cell migration of the preosteoblast towards the loaded and unloaded
HNTs, we tried using Gradient Tech cell migration 2D construct. The study was
inconclusive as it required the use of fluorescent microscope for 48 hours. The results
obtained for a period of 8 hours were inconclusive and we had to settle for the
histological staining of the cells seeded on the collagen gel matrices.

